[1m[31mPubmed ID: 32019791[0m

title: Influence of Plant Fraction, Soil, and Plant Species on Microbiota: a Multikingdom Comparison [æ¤ç‰©ç»„æˆï¼ŒåœŸå£¤å’Œæ¤ç‰©ç‰©ç§å¯¹å¾®ç”Ÿç‰©ç¾¤è½çš„å½±å“ï¼šå¤šç‹å›½æ¯”è¾ƒ]

doi: 10.1128/mBio.02785-19

link_url: https://pubmed.ncbi.nlm.nih.gov/32019791/

journal: mBio

date: 02/04/2020

enc_abstract: Plant roots influence the soil microbiota via physical interaction, secretion, and plant immunity. However, it is unclear whether the root fraction or soil is more important in determining the structure of the prokaryotic or eukaryotic community and whether this varies between plant species. Furthermore, the leaf (phyllosphere) and root microbiotas have a large overlap; however, it is unclear whether this results from colonization of the phyllosphere by the root microbiota. Soil, rhizosphere, rhizoplane, and root endosphere prokaryote-, eukaryote-, and fungus-specific microbiotas of four plant species were analyzed with high-throughput sequencing. The strengths of factors controlling microbiota structure were determined using permutational multivariate analysis of variance (PERMANOVA) statistics. The origin of the phyllosphere microbiota was investigated using a soil swap experiment. Global microbial kingdom analysis conducted simultaneously on multiple plants shows that cereals, legumes, and Brassicaceae establish similar prokaryotic and similar eukaryotic communities inside and on the root surface. While the bacterial microbiota is recruited from the surrounding soil, its profile is influenced by the root itself more so than by soil or plant species. However, in contrast, the fungal microbiota is most strongly influenced by soil. This was observed in two different soils and for all plant species examined. Microbiota structure is established within 2 weeks of plant growth in soil and remains stable thereafter. A reciprocal soil swap experiment shows that the phyllosphere is colonized from the soil in which the plant is grown.IMPORTANCE Global microbial kingdom analysis conducted simultaneously on multiple plants shows that cereals, legumes, and Brassicaceae establish similar prokaryotic and similar eukaryotic communities inside and on the root surface. While the bacterial microbiota is recruited from the surrounding soil, its profile is influenced by the root fraction more so than by soil or plant species. However, in contrast, the fungal microbiota is most strongly influenced by soil. This was observed in two different soils and for all plant species examined, indicating conserved adaptation of microbial communities to plants. Microbiota structure is established within 2 weeks of plant growth in soil and remains stable thereafter. We observed a remarkable similarity in the structure of a plant's phyllosphere and root microbiotas and show by reciprocal soil swap experiments that both fractions are colonized from the soil in which the plant is grown. Thus, the phyllosphere is continuously colonized by the soil microbiota.          

cn_abstract: æ¤ç‰©æ ¹ç³»é€šè¿‡ç‰©ç†ç›¸äº’ä½œç”¨ï¼Œåˆ†æ³Œå’Œæ¤ç‰©å…ç–«åŠ›å½±å“åœŸå£¤å¾®ç”Ÿç‰©ã€‚ä½†æ˜¯ï¼Œå°šä¸æ¸…æ¥šæ ¹éƒ¨åˆ†æˆ–åœŸå£¤åœ¨ç¡®å®šåŸæ ¸æˆ–çœŸæ ¸ç¾¤è½çš„ç»“æ„ä»¥åŠæ¤ç‰©ç‰©ç§ä¹‹é—´æ˜¯å¦æœ‰æ‰€ä¸åŒæ–¹é¢æ˜¯å¦æ›´ä¸ºé‡è¦ã€‚æ­¤å¤–ï¼Œå¶ï¼ˆå¶å±‚ï¼‰å’Œæ ¹å¾®ç”Ÿç‰©åŒºç³»æœ‰å¾ˆå¤§çš„é‡å ã€‚ç„¶è€Œï¼Œç›®å‰å°šä¸æ¸…æ¥šè¿™æ˜¯å¦æ˜¯æ ¹ç³»èŒç¾¤å¯¹å¶çƒå®šæ¤çš„ç»“æœã€‚ä½¿ç”¨é«˜é€šé‡æµ‹åºåˆ†æäº†å››ç§æ¤ç‰©çš„åœŸå£¤ï¼Œæ ¹é™…ï¼Œæ ¹é™…å¹³é¢å’Œæ ¹å†…çƒåŸæ ¸ç”Ÿç‰©ï¼ŒçœŸæ ¸ç”Ÿç‰©å’ŒçœŸèŒç‰¹æœ‰çš„å¾®ç”Ÿç‰©ç¾¤ã€‚ä½¿ç”¨æ’åˆ—å¤šå…ƒæ–¹å·®åˆ†æï¼ˆPERMANOVAï¼‰ç»Ÿè®¡æ•°æ®ç¡®å®šæ§åˆ¶å¾®ç”Ÿç‰©ç¾¤ç»“æ„çš„å› ç´ çš„å¼ºåº¦ã€‚ä½¿ç”¨åœŸå£¤äº¤æ¢å®éªŒç ”ç©¶äº†å¶åœˆå¾®ç”Ÿç‰©ç¾¤çš„èµ·æºã€‚åŒæ—¶åœ¨å¤šç§æ¤ç‰©ä¸Šè¿›è¡Œçš„å…¨çƒå¾®ç”Ÿç‰©ç‹å›½åˆ†æè¡¨æ˜ï¼Œè°·ç‰©ï¼Œè±†ç±»å’Œåå­—èŠ±ç§‘åœ¨æ ¹è¡¨é¢å†…å’Œæ ¹è¡¨é¢å»ºç«‹äº†ç›¸ä¼¼çš„åŸæ ¸å’Œç›¸ä¼¼çš„çœŸæ ¸ç”Ÿç‰©ç¾¤è½ã€‚è™½ç„¶ç»†èŒå¾®ç”Ÿç‰©ç¾¤æ˜¯ä»å‘¨å›´çš„åœŸå£¤ä¸­å‹Ÿé›†çš„ï¼Œä½†å…¶æ ¹ç³»å—æ ¹æœ¬èº«çš„å½±å“è¦å¤§äºåœŸå£¤æˆ–æ¤ç‰©ç‰©ç§çš„å½±å“ã€‚ä½†æ˜¯ï¼Œç›¸åï¼ŒçœŸèŒå¾®ç”Ÿç‰©ç¾¤å—åœŸå£¤çš„å½±å“æœ€å¤§ã€‚åœ¨ä¸¤ç§ä¸åŒçš„åœŸå£¤ä»¥åŠæ‰€æ£€æŸ¥çš„æ‰€æœ‰æ¤ç‰©ç‰©ç§ä¸­å‡è§‚å¯Ÿåˆ°äº†è¿™ä¸€ç‚¹ã€‚å¾®ç”Ÿç‰©ç¾¤çš„ç»“æ„åœ¨æ¤ç‰©åœ¨åœŸå£¤ä¸­ç”Ÿé•¿çš„2å‘¨å†…å»ºç«‹ï¼Œå¹¶åœ¨æ­¤åä¿æŒç¨³å®šã€‚ç›¸äº’çš„åœŸå£¤äº¤æ¢å®éªŒè¡¨æ˜ï¼Œå¶ç¯æ˜¯ä»ç§æ¤æ¤ç‰©çš„åœŸå£¤ä¸­å®šæ¤çš„ã€‚é‡è¦äº‹é¡¹å¯¹å¤šç§æ¤ç‰©åŒæ—¶è¿›è¡Œçš„å…¨çƒå¾®ç”Ÿç‰©ç•Œåˆ†æè¡¨æ˜ï¼Œè°·ç‰©ï¼Œè±†ç±»å’Œåå­—èŠ±ç§‘åœ¨å…¶å†…éƒ¨å’Œå¤–éƒ¨å»ºç«‹äº†ç›¸ä¼¼çš„åŸæ ¸å’Œç›¸ä¼¼çš„çœŸæ ¸ç”Ÿç‰©ç¾¤è½ã€‚æ ¹è¡¨é¢ã€‚è™½ç„¶ç»†èŒå¾®ç”Ÿç‰©ç¾¤æ˜¯ä»å‘¨å›´çš„åœŸå£¤ä¸­å‹Ÿé›†çš„ï¼Œä½†å…¶åˆ†å¸ƒçŠ¶å†µå—æ ¹éƒ¨åˆ†çš„å½±å“è¦å¤§äºåœŸå£¤æˆ–æ¤ç‰©ç‰©ç§çš„å½±å“ã€‚ä½†æ˜¯ï¼Œç›¸åï¼ŒçœŸèŒå¾®ç”Ÿç‰©ç¾¤å—åœŸå£¤çš„å½±å“æœ€å¤§ã€‚åœ¨ä¸¤ç§ä¸åŒçš„åœŸå£¤ä¸­ä»¥åŠæ‰€æœ‰è¢«æ£€æŸ¥çš„æ¤ç‰©ç‰©ç§ä¸­éƒ½è§‚å¯Ÿåˆ°äº†è¿™ä¸€ç‚¹ï¼Œè¡¨æ˜å¾®ç”Ÿç‰©ç¾¤è½å¯¹æ¤ç‰©çš„ä¿å®ˆé€‚åº”æ€§ã€‚å¾®ç”Ÿç‰©ç¾¤çš„ç»“æ„åœ¨æ¤ç‰©åœ¨åœŸå£¤ä¸­ç”Ÿé•¿çš„2å‘¨å†…å»ºç«‹ï¼Œå¹¶åœ¨æ­¤åä¿æŒç¨³å®šã€‚æˆ‘ä»¬è§‚å¯Ÿåˆ°äº†æ¤ç‰©çš„å¶çƒç»“æ„å’Œæ ¹å¾®ç”Ÿç‰©åŒºç³»çš„æ˜¾ç€ç›¸ä¼¼æ€§ï¼Œå¹¶é€šè¿‡ç›¸äº’çš„åœŸå£¤äº¤æ¢å®éªŒè¡¨æ˜ï¼Œè¿™ä¸¤ä¸ªéƒ¨åˆ†éƒ½æ˜¯ä»æ¤ç‰©ç”Ÿé•¿çš„åœŸå£¤ä¸­å®šæ¤çš„ã€‚å› æ­¤ï¼Œå¶ç¯è¢«åœŸå£¤å¾®ç”Ÿç‰©ç¾¤ä¸æ–­åœ°å®šæ®–ã€‚

[1m[33m####################################################################################################[0m

[1m[31mPubmed ID: 32019793[0m

title: Endotoxin Producers Overgrowing in Human Gut Microbiota as the Causative Agents for Nonalcoholic Fatty Liver Disease [å†…æ¯’ç´ ç”Ÿäº§è€…åœ¨äººç±»è‚ é“èŒç¾¤ä¸­ç”Ÿé•¿è¿‡å¤šï¼Œæˆä¸ºéé…’ç²¾æ€§è„‚è‚ªè‚ç—…çš„è‡´ç—…å› å­]

doi: 10.1128/mBio.03263-19

link_url: https://pubmed.ncbi.nlm.nih.gov/32019793/

journal: mBio

date: 02/04/2020

enc_abstract: Gut microbiota-derived endotoxin has been linked to human nonalcoholic fatty liver disease (NAFLD), but the specific causative agents and their molecular mechanisms remain elusive. In this study, we investigated whether bacterial strains of endotoxin-producing pathogenic species overgrowing in obese human gut can work as causative agents for NAFLD. We further assessed the role of lipopolysaccharide (LPS)-Toll-like receptor 4 (TLR4) cross talk in this pathogenicity. Nonvirulent strains of Gram-negative pathobionts were isolated from obese human gut and monoassociated with C57BL/6J germfree (GF) mice fed a high-fat diet (HFD). Deletion of waaG in the bacterial endotoxin synthetic pathway and knockout of TLR4 in GF mice were used to further study the underlying mechanism for a causal relationship between these strains and the development of NAFLD. Three endotoxin-producing strains, Enterobacter cloacae B29, Escherichia coli PY102, and Klebsiella pneumoniae A7, overgrowing in the gut of morbidly obese volunteers with severe fatty liver, induced NAFLD when monoassociated with GF mice on HFD, while HFD alone did not induce the disease in GF mice. The commensal Bacteroides thetaiotaomicron (ATCC 29148), whose endotoxin activity was markedly lower than that of Enterobacteriaceae strains, did not induce NAFLD in GF mice. B29 lost its proinflammatory properties and NAFLD-inducing capacity upon deletion of the waaG gene. Moreover, E. cloacae B29 did not induce NAFLD in TLR4-deficient GF mice. These nonvirulent endotoxin-producing strains in pathobiont species overgrowing in human gut may work as causative agents, with LPS-TLR4 cross talk as the most upstream and essential molecular event for NAFLD.IMPORTANCE Recent studies have reported a link between gut microbiota and nonalcoholic fatty liver disease (NAFLD), showing that germfree (GF) mice do not develop metabolic syndromes, including NAFLD. However, the specific bacterial species causing NAFLD, as well as their molecular cross talk with the host for driving liver disease, remain elusive. Here, we found that nonvirulent endotoxin-producing strains of pathogenic species overgrowing in obese human gut can act as causative agents for induction of NAFLD and related metabolic disorders. The cross talk between endotoxin from these specific producers and the host's TLR4 receptor is the most upstream and essential molecular event for inducing all phenotypes in NAFLD and related metabolic disorders. These nonvirulent endotoxin-producing strains of gut pathogenic species overgrowing in human gut may collectively become a predictive biomarker or serve as a novel therapeutic target for NAFLD and related metabolic disorders.          

cn_abstract: è‚ é“èŒç¾¤æ¥æºçš„å†…æ¯’ç´ å·²ç»ä¸äººç±»éé…’ç²¾æ€§è„‚è‚ªè‚ç–¾ç—…ï¼ˆNAFLDï¼‰ç›¸å…³ï¼Œä½†æ˜¯å…·ä½“çš„ç—…å› åŠå…¶åˆ†å­æœºåˆ¶ä»ç„¶éš¾ä»¥æ‰æ‘¸ã€‚åœ¨è¿™é¡¹ç ”ç©¶ä¸­ï¼Œæˆ‘ä»¬è°ƒæŸ¥äº†è‚¥èƒ–äººç±»è‚ é“ä¸­è¿‡åº¦ç”Ÿé•¿çš„äº§ç”Ÿå†…æ¯’ç´ è‡´ç—…èŒçš„ç»†èŒèŒæ ªæ˜¯å¦å¯ä»¥ä½œä¸ºNAFLDçš„ç—…åŸä½“ã€‚æˆ‘ä»¬è¿›ä¸€æ­¥è¯„ä¼°äº†è„‚å¤šç³–ï¼ˆLPSï¼‰-Tollæ ·å—ä½“4ï¼ˆTLR4ï¼‰ä¸²æ‰°åœ¨è¿™ç§è‡´ç—…æ€§ä¸­çš„ä½œç”¨ã€‚ä»è‚¥èƒ–çš„äººè‚ ä¸­åˆ†ç¦»å‡ºé©å…°æ°é˜´æ€§è‡´ç—…èŒçš„æ— æ¯’æ ªï¼Œå¹¶ä¸é«˜è„‚é¥®é£Ÿï¼ˆHFDï¼‰å–‚å…»çš„C57BL / 6Jæ— èŒï¼ˆGFï¼‰å°é¼ å•è”ã€‚åœ¨ç»†èŒå†…æ¯’ç´ åˆæˆé€”å¾„ä¸­åˆ é™¤waaGå’Œåœ¨GFå°é¼ ä¸­æ•²é™¤TLR4è¢«ç”¨äºè¿›ä¸€æ­¥ç ”ç©¶è¿™äº›èŒæ ªä¸NAFLDå‘ç”Ÿä¹‹é—´å› æœå…³ç³»çš„æ½œåœ¨æœºåˆ¶ã€‚åœ¨å¸¦æœ‰ä¸¥é‡è„‚è‚ªè‚çš„ç—…æ€è‚¥èƒ–å¿—æ„¿è€…çš„è‚ é“ä¸­ç”Ÿé•¿è¿‡åº¦çš„ä¸‰ç§å†…æ¯’ç´ äº§ç”Ÿæ ªï¼Œé˜´æ²Ÿè‚ æ†èŒB29ï¼Œå¤§è‚ æ†èŒPY102å’Œè‚ºç‚å…‹é›·ä¼¯èŒè‚ºç‚A7ï¼Œå½“ä¸GFå°é¼ åœ¨HFDä¸Šå•è¯ç»“åˆæ—¶ï¼Œä¼šå¼•èµ·NAFâ€‹â€‹LDï¼Œè€Œå•ç‹¬çš„HFDä¸ä¼šè¯±å‘è¿™ç§ç–¾ç—…ã€‚åœ¨GFå°é¼ ä¸­ã€‚å†…æ¯’ç´ æ´»æ€§æ˜æ˜¾ä½äºè‚ æ†èŒç§‘èŒæ ªçš„å…±ç”Ÿæ‹Ÿæ†èŒæ†èŒï¼ˆATCC 29148ï¼‰ä¸ä¼šåœ¨GFå°é¼ ä¸­è¯±å¯¼NAFLDã€‚ waaGåŸºå› ç¼ºå¤±åï¼ŒB29ä¸§å¤±äº†ä¿ƒç‚ç‰¹æ€§å’ŒNAFLDè¯±å¯¼èƒ½åŠ›ã€‚è€Œä¸”ï¼Œé˜´æ²Ÿè‚ æ†èŒB29åœ¨TLR4ç¼ºé™·å‹GFå°é¼ ä¸­ä¸è¯±å¯¼NAFLDã€‚è¿™äº›åœ¨äººç±»è‚ é“ä¸­è¿‡åº¦ç”Ÿé•¿çš„ç—…åŸä½“ç‰©ç§ä¸­äº§ç”Ÿéæ¯’æ€§å†…æ¯’ç´ çš„èŒæ ªå¯èƒ½æ˜¯ç—…åŸä½“ï¼ŒLPS-TLR4ä¸²æ‰°æ˜¯NAFLDçš„æœ€ä¸Šæ¸¸å’Œå¿…ä¸å¯å°‘çš„åˆ†å­äº‹ä»¶ã€‚é‡è¦ç ”ç©¶è¡¨æ˜ï¼Œè‚ é“èŒç¾¤ä¸éé…’ç²¾æ€§è„‚è‚ªè‚ä¹‹é—´å­˜åœ¨è”ç³»ç—…ï¼ˆNAFLDï¼‰ï¼Œè¡¨æ˜æ— èŒï¼ˆGFï¼‰å°é¼ ä¸ä¼šå‘å±•åŒ…æ‹¬NAFLDåœ¨å†…çš„ä»£è°¢ç»¼åˆå¾ã€‚ç„¶è€Œï¼Œå¼•èµ·NAFâ€‹â€‹LDçš„ç‰¹å®šç»†èŒç§ç±»ï¼Œä»¥åŠä¸å®¿ä¸»é©±åŠ¨è‚ç—…çš„åˆ†å­ä¸²æ‰°ä»ç„¶éš¾ä»¥æ‰æ‘¸ã€‚åœ¨è¿™é‡Œï¼Œæˆ‘ä»¬å‘ç°è‚¥èƒ–äººç±»è‚ é“ä¸­è¿‡åº¦ç”Ÿé•¿çš„è‡´ç—…ç‰©ç§çš„æ— æ¯’å†…æ¯’ç´ äº§ç”ŸèŒæ ªå¯ä»¥ä½œä¸ºè¯±å¯¼NAFLDå’Œç›¸å…³ä»£è°¢å¼‚å¸¸çš„ç—…åŸä½“ã€‚è¿™äº›ç‰¹å®šç”Ÿäº§è€…çš„å†…æ¯’ç´ ä¸å®¿ä¸»çš„TLR4å—ä½“ä¹‹é—´çš„ç›¸äº’å¹²æ‰°æ˜¯è¯±å¯¼NAFLDå’Œç›¸å…³ä»£è°¢å¼‚å¸¸ä¸­æ‰€æœ‰è¡¨å‹çš„æœ€ä¸Šæ¸¸å’Œæœ€åŸºæœ¬çš„åˆ†å­äº‹ä»¶ã€‚è¿™äº›åœ¨äººç±»è‚ é“ä¸­è¿‡åº¦ç”Ÿé•¿çš„è‚ é“ç—…åŸä½“çš„æ— æ¯’å†…æ¯’ç´ äº§ç”ŸèŒæ ªå¯èƒ½å…±åŒæˆä¸ºé¢„æµ‹æ€§ç”Ÿç‰©æ ‡å¿—ç‰©ï¼Œæˆ–ä½œä¸ºNAFLDå’Œç›¸å…³ä»£è°¢ç´Šä¹±çš„æ–°å‹æ²»ç–—é¶æ ‡ã€‚

[1m[33m####################################################################################################[0m

[1m[31mPubmed ID: 32019796[0m

title: Erratum for Kumar et al., "Indole Signaling at the Host-Microbiota-Pathogen Interface" [Kumarç­‰äººçš„å‹˜è¯¯ï¼Œâ€œå®¿ä¸»-å¾®ç”Ÿç‰©-ç—…åŸä½“ç•Œé¢å¤„çš„å²å“šä¿¡å·ä¼ å¯¼â€]

doi: 10.1128/mBio.03318-19

link_url: https://pubmed.ncbi.nlm.nih.gov/32019796/

journal: mBio

date: 02/04/2020

enc_abstract: No abstract

cn_abstract: æ²¡æœ‰æ‘˜è¦

[1m[33m####################################################################################################[0m

[1m[31mPubmed ID: 32071263[0m

title: New View on Dietary Fiber Selection for Predictable Shifts in Gut Microbiota [è†³é£Ÿçº¤ç»´é€‰æ‹©å¯é¢„æµ‹è‚ é“èŒç¾¤è½¬å˜çš„æ–°è§‚ç‚¹]

doi: 10.1128/mBio.02179-19

link_url: https://pubmed.ncbi.nlm.nih.gov/32071263/

journal: mBio

date: 02/18/2020

enc_abstract: Dietary fibers can be utilized to shape the human gut microbiota. However, the outcomes from most dietary fibers currently used as prebiotics are a result of competition between microbes with overlapping abilities to utilize these fibers. Thus, divergent fiber responses are observed across individuals harboring distinct microbial communities. Here, we propose that dietary fibers can be classified hierarchically according to their specificity toward gut microbes. Highly specific fibers harbor chemical and physical characteristics that allow them to be utilized by only a narrow group of bacteria within the gut, reducing competition for that substrate. The use of such fibers as prebiotics targeted to specific microbes would result in predictable shifts independent of the background microbial composition.          

cn_abstract: è†³é£Ÿçº¤ç»´å¯ç”¨äºå¡‘é€ äººä½“è‚ é“èŒç¾¤ã€‚ç„¶è€Œï¼Œç›®å‰ç”¨ä½œç›Šç”Ÿå…ƒçš„å¤§å¤šæ•°è†³é£Ÿçº¤ç»´çš„ç»“æœæ˜¯å¾®ç”Ÿç‰©ä¹‹é—´ç«äº‰çš„ç»“æœï¼Œè¿™äº›å¾®ç”Ÿç‰©å…·æœ‰é‡å çš„åˆ©ç”¨è¿™äº›çº¤ç»´çš„èƒ½åŠ›ã€‚å› æ­¤ï¼Œåœ¨å…·æœ‰ä¸åŒå¾®ç”Ÿç‰©ç¾¤è½çš„ä¸ªä½“ä¹‹é—´è§‚å¯Ÿåˆ°ä¸åŒçš„çº¤ç»´ååº”ã€‚åœ¨è¿™é‡Œï¼Œæˆ‘ä»¬å»ºè®®è†³é£Ÿçº¤ç»´å¯ä»¥æ ¹æ®å®ƒä»¬å¯¹è‚ é“å¾®ç”Ÿç‰©çš„ç‰¹å¼‚æ€§è¿›è¡Œåˆ†çº§ã€‚é«˜åº¦ç‰¹æ®Šçš„çº¤ç»´å…·æœ‰åŒ–å­¦å’Œç‰©ç†ç‰¹æ€§ï¼Œä½¿å®ƒä»¬ä»…èƒ½è¢«è‚ é“å†…ä¸€å°éƒ¨åˆ†ç»†èŒåˆ©ç”¨ï¼Œä»è€Œå‡å°‘äº†å¯¹è¯¥åº•ç‰©çš„ç«äº‰ã€‚æ­¤ç±»çº¤ç»´ä½œä¸ºé’ˆå¯¹ç‰¹å®šå¾®ç”Ÿç‰©çš„ç›Šç”Ÿå…ƒçš„ä½¿ç”¨å°†å¯¼è‡´å¯é¢„æµ‹çš„è½¬å˜ï¼Œè€Œä¸èƒŒæ™¯å¾®ç”Ÿç‰©ç»„æˆæ— å…³ã€‚

[1m[33m####################################################################################################[0m

[1m[31mPubmed ID: 32071266[0m

title: Fecal Metabolomic Signatures in Colorectal Adenoma Patients Are Associated with Gut Microbiota and Early Events of Colorectal Cancer Pathogenesis [å¤§è‚ è…ºç˜¤æ‚£è€…çš„ç²ªä¾¿ä»£è°¢ç»„å­¦ç‰¹å¾ä¸è‚ é“èŒç¾¤å’Œå¤§è‚ ç™Œå‘ç—…æœºç†çš„æ—©æœŸäº‹ä»¶æœ‰å…³]

doi: 10.1128/mBio.03186-19

link_url: https://pubmed.ncbi.nlm.nih.gov/32071266/

journal: mBio

date: 02/18/2020

enc_abstract: Colorectal adenomas are precancerous lesions of colorectal cancer (CRC) that offer a means of viewing the events key to early CRC development. A number of studies have investigated the changes and roles of gut microbiota in adenoma and carcinoma development, highlighting its impact on carcinogenesis. However, there has been less of a focus on the gut metabolome, which mediates interactions between the host and gut microbes. Here, we investigated metabolomic profiles of stool samples from patients with advanced adenoma (n = 102), matched controls (n = 102), and patients with CRC (n = 36). We found that several classes of bioactive lipids, including polyunsaturated fatty acids, secondary bile acids, and sphingolipids, were elevated in the adenoma patients compared to the controls. Most such metabolites showed directionally consistent changes in the CRC patients, suggesting that those changes may represent early events of carcinogenesis. We also examined gut microbiome-metabolome associations using gut microbiota profiles in these patients. We found remarkably strong overall associations between the microbiome and metabolome data and catalogued a list of robustly correlated pairs of bacterial taxa and metabolomic features which included signatures of adenoma. Our findings highlight the importance of gut metabolites, and potentially their interplay with gut microbes, in the early events of CRC pathogenesis.IMPORTANCE Colorectal adenomas are precursors of CRC. Recently, the gut microbiota, i.e., the collection of microbes residing in our gut, has been recognized as a key player in CRC development. There have been a number of gut microbiota profiling studies for colorectal adenoma and CRC; however, fewer studies have considered the gut metabolome, which serves as the chemical interface between the host and gut microbiota. Here, we conducted a gut metabolome profiling study of colorectal adenoma and CRC and analyzed the metabolomic profiles together with paired microbiota composition profiles. We found several chemical signatures of colorectal adenoma that were associated with some gut microbes and potentially indicative of future CRC. This study highlights potential early-driver metabolites in CRC pathogenesis and guides further targeted experiments and thus provides an important stepping stone toward developing better CRC prevention strategies.          

cn_abstract: ç»“ç›´è‚ è…ºç˜¤æ˜¯ç»“ç›´è‚ ç™Œï¼ˆCRCï¼‰çš„ç™Œå‰ç—…å˜ï¼Œå¯æä¾›ä¸€ç§æŸ¥çœ‹äº‹ä»¶çš„æ–¹æ³•ï¼Œè¿™äº›äº‹ä»¶æ˜¯CRCæ—©æœŸå‘å±•çš„å…³é”®ã€‚å¤§é‡ç ”ç©¶è°ƒæŸ¥äº†è‚ é“èŒç¾¤åœ¨è…ºç˜¤å’Œç™Œå˜è¿‡ç¨‹ä¸­çš„å˜åŒ–åŠå…¶ä½œç”¨ï¼Œçªå‡ºäº†å…¶å¯¹ç™Œå˜çš„å½±å“ã€‚ä½†æ˜¯ï¼Œäººä»¬å¯¹è‚ é“ä»£è°¢ç»„çš„å…³æ³¨è¾ƒå°‘ï¼Œè‚ é“ä»£è°¢ç»„ä»‹å¯¼å®¿ä¸»ä¸è‚ é“å¾®ç”Ÿç‰©ä¹‹é—´çš„ç›¸äº’ä½œç”¨ã€‚åœ¨è¿™é‡Œï¼Œæˆ‘ä»¬ç ”ç©¶äº†æ¥è‡ªæ™šæœŸè…ºç˜¤ï¼ˆn = 102ï¼‰ï¼ŒåŒ¹é…çš„å¯¹ç…§ï¼ˆn = 102ï¼‰å’ŒCRCï¼ˆn = 36ï¼‰æ‚£è€…ç²ªä¾¿æ ·æœ¬çš„ä»£è°¢ç»„å­¦ç‰¹å¾ã€‚æˆ‘ä»¬å‘ç°ï¼Œä¸å¯¹ç…§ç»„ç›¸æ¯”ï¼Œè…ºç˜¤æ‚£è€…çš„å‡ ç±»ç”Ÿç‰©æ´»æ€§è„‚è´¨ï¼ŒåŒ…æ‹¬å¤šä¸é¥±å’Œè„‚è‚ªé…¸ï¼Œä»²èƒ†æ±é…¸å’Œé˜è„‚ï¼Œå‡å‡é«˜ã€‚å¤§å¤šæ•°æ­¤ç±»ä»£è°¢ç‰©åœ¨CRCæ‚£è€…ä¸­æ˜¾ç¤ºå‡ºæ–¹å‘ä¸€è‡´çš„å˜åŒ–ï¼Œè¡¨æ˜è¿™äº›å˜åŒ–å¯èƒ½ä»£è¡¨äº†ç™Œå˜çš„æ—©æœŸäº‹ä»¶ã€‚æˆ‘ä»¬è¿˜ä½¿ç”¨è¿™äº›æ‚£è€…çš„è‚ é“èŒç¾¤è°±æ£€æŸ¥äº†è‚ é“èŒç¾¤ä¸ä»£è°¢ç»„çš„å…³ç³»ã€‚æˆ‘ä»¬å‘ç°å¾®ç”Ÿç‰©ç»„å’Œä»£è°¢ç»„æ•°æ®ä¹‹é—´çš„æ•´ä½“å…³è”éå¸¸æ˜æ˜¾ï¼Œå¹¶åˆ—å‡ºäº†ç»†èŒåˆ†ç±»ç¾¤å’Œä»£è°¢ç»„å­¦ç‰¹å¾ï¼ˆåŒ…æ‹¬è…ºç˜¤çš„ç‰¹å¾ï¼‰ä¹‹é—´çš„ç›¸å…³æ€§å¼ºçš„åˆ—è¡¨ã€‚æˆ‘ä»¬çš„å‘ç°çªå‡ºäº†è‚ é“ä»£è°¢ç‰©åœ¨CRCå‘ç—…æœºç†çš„æ—©æœŸäº‹ä»¶ä¸­çš„é‡è¦æ€§ä»¥åŠä¸è‚ é“å¾®ç”Ÿç‰©ç›¸äº’ä½œç”¨çš„å¯èƒ½æ€§ã€‚é‡è¦ç»“ç›´è‚ è…ºç˜¤æ˜¯CRCçš„å‰ä½“ã€‚æœ€è¿‘ï¼Œè‚ é“èŒç¾¤ï¼Œå³æˆ‘ä»¬è‚ é“ä¸­çš„å¾®ç”Ÿç‰©é›†åˆï¼Œè¢«å…¬è®¤ä¸ºæ˜¯CRCå‘å±•çš„å…³é”®å› ç´ ã€‚å·²ç»æœ‰è®¸å¤šé’ˆå¯¹ç»“è‚ ç›´è‚ è…ºç˜¤å’ŒCRCçš„è‚ é“èŒç¾¤åˆ†æç ”ç©¶ï¼›ç„¶è€Œï¼Œå¾ˆå°‘æœ‰ç ”ç©¶è€ƒè™‘è‚ é“ä»£è°¢ç»„ï¼Œå®ƒæ˜¯å®¿ä¸»å’Œè‚ é“èŒç¾¤ä¹‹é—´çš„åŒ–å­¦ç•Œé¢ã€‚åœ¨è¿™é‡Œï¼Œæˆ‘ä»¬è¿›è¡Œäº†å¤§è‚ è…ºç˜¤å’ŒCRCçš„è‚ é“ä»£è°¢ç»„è°±åˆ†æï¼Œå¹¶åˆ†æäº†ä»£è°¢ç»„å­¦è°±ä»¥åŠé…å¯¹çš„å¾®ç”Ÿç‰©ç¾¤ç»„æˆè°±ã€‚æˆ‘ä»¬å‘ç°äº†å¤§è‚ è…ºç˜¤çš„ä¸€äº›åŒ–å­¦ç‰¹å¾ï¼Œè¿™äº›åŒ–å­¦ç‰¹å¾ä¸æŸäº›è‚ é“å¾®ç”Ÿç‰©æœ‰å…³ï¼Œå¹¶å¯èƒ½é¢„ç¤ºç€æœªæ¥çš„CRCã€‚è¿™é¡¹ç ”ç©¶çªå‡ºäº†CRCå‘ç—…æœºç†ä¸­æ½œåœ¨çš„æ—©æœŸé©±åŠ¨ç‰©ä»£è°¢äº§ç‰©ï¼Œå¹¶æŒ‡å¯¼äº†è¿›ä¸€æ­¥çš„é’ˆå¯¹æ€§å®éªŒï¼Œä»è€Œä¸ºå¼€å‘æ›´å¥½çš„CRCé¢„é˜²ç­–ç•¥æä¾›äº†é‡è¦çš„è¸è„šçŸ³ã€‚

[1m[33m####################################################################################################[0m

[1m[31mPubmed ID: 32071269[0m

title: Respiratory Viral Infection Alters the Gut Microbiota by Inducing Inappetence [å‘¼å¸é“ç—…æ¯’æ„ŸæŸ“é€šè¿‡è¯±å¯¼é£Ÿæ¬²ä¸æŒ¯æ”¹å˜è‚ é“èŒç¾¤ã€‚]

doi: 10.1128/mBio.03236-19

link_url: https://pubmed.ncbi.nlm.nih.gov/32071269/

journal: mBio

date: 02/18/2020

enc_abstract: Respiratory viral infections are extremely common, but their impacts on the composition and function of the gut microbiota are poorly understood. We previously observed a significant change in the gut microbiota after viral lung infection. Here, we show that weight loss during respiratory syncytial virus (RSV) or influenza virus infection was due to decreased food consumption, and that the fasting of mice altered gut microbiota composition independently of infection. While the acute phase tumor necrosis factor alpha (TNF-Î±) response drove early weight loss and inappetence during RSV infection, this was not sufficient to induce changes in the gut microbiota. However, the depletion of CD8+ cells increased food intake and prevented weight loss, resulting in a reversal of the gut microbiota changes normally observed during RSV infection. Viral infection also led to changes in the fecal gut metabolome, with a significant shift in lipid metabolism. Sphingolipids, polyunsaturated fatty acids (PUFAs), and the short-chain fatty acid (SCFA) valerate were all increased in abundance in the fecal metabolome following RSV infection. Whether this and the impact of infection-induced anorexia on the gut microbiota are part of a protective anti-inflammatory response during respiratory viral infections remains to be determined.IMPORTANCE The gut microbiota has an important role in health and disease: gut bacteria can generate metabolites that alter the function of immune cells systemically. Understanding the factors that can lead to changes in the gut microbiome may help to inform therapeutic interventions. This is the first study to systematically dissect the pathway of events from viral lung infection to changes in gut microbiota. We show that the cellular immune response to viral lung infection induces inappetence, which in turn alters the gut microbiome and metabolome. Strikingly, there was an increase in lipids that have been associated with the resolution of disease. This opens up new paths of investigation: first, what is the (presumably secreted) factor made by the T cells that can induce inappetence? Second, is inappetence an adaptation that accelerates recovery from infection, and if so, does the microbiome play a role in this?          

cn_abstract: å‘¼å¸é“ç—…æ¯’æ„ŸæŸ“æä¸ºå¸¸è§ï¼Œä½†å¯¹è‚ é“èŒç¾¤ç»„æˆå’ŒåŠŸèƒ½çš„å½±å“çŸ¥ä¹‹ç”šå°‘ã€‚æˆ‘ä»¬å…ˆå‰è§‚å¯Ÿåˆ°ç—…æ¯’æ€§è‚ºéƒ¨æ„ŸæŸ“åè‚ é“èŒç¾¤å‘ç”Ÿäº†æ˜¾ç€å˜åŒ–ã€‚åœ¨è¿™é‡Œï¼Œæˆ‘ä»¬æ˜¾ç¤ºå‘¼å¸é“åˆèƒç—…æ¯’ï¼ˆRSVï¼‰æˆ–æµæ„Ÿç—…æ¯’æ„ŸæŸ“æœŸé—´ä½“é‡å‡è½»æ˜¯ç”±äºé£Ÿç‰©æ¶ˆè€—å‡å°‘ï¼Œå¹¶ä¸”å°é¼ çš„ç¦é£Ÿç‹¬ç«‹äºæ„ŸæŸ“è€Œæ”¹å˜äº†è‚ é“èŒç¾¤ç»„æˆã€‚è™½ç„¶æ€¥æ€§æœŸè‚¿ç˜¤åæ­»å› å­Î±ï¼ˆTNF-Î±ï¼‰ååº”å¯¼è‡´RSVæ„ŸæŸ“æœŸé—´æ—©æœŸä½“é‡å‡è½»å’Œé£Ÿæ¬²ä¸æŒ¯ï¼Œä½†è¿™ä¸è¶³ä»¥è¯±å‘è‚ é“èŒç¾¤çš„å˜åŒ–ã€‚ä½†æ˜¯ï¼ŒCD8 +ç»†èƒçš„æ¶ˆè€—å¢åŠ äº†é£Ÿç‰©æ‘„å…¥å¹¶é˜²æ­¢äº†ä½“é‡å‡è½»ï¼Œä»è€Œå¯¼è‡´äº†åœ¨RSVæ„ŸæŸ“æœŸé—´é€šå¸¸è§‚å¯Ÿåˆ°çš„è‚ é“èŒç¾¤å˜åŒ–çš„é€†è½¬ã€‚ç—…æ¯’æ„ŸæŸ“è¿˜å¯¼è‡´ç²ªä¾¿è‚ é“ä»£è°¢ç»„å‘ç”Ÿå˜åŒ–ï¼Œè„‚è´¨ä»£è°¢å‘ç”Ÿæ˜æ˜¾å˜åŒ–ã€‚ RSVæ„ŸæŸ“åï¼Œç²ªä¾¿ä»£è°¢ç»„ä¸­çš„é˜è„‚ï¼Œå¤šä¸é¥±å’Œè„‚è‚ªé…¸ï¼ˆPUFAï¼‰å’ŒçŸ­é“¾è„‚è‚ªé…¸ï¼ˆSCFAï¼‰æˆŠé…¸é…¯å‡å¢åŠ ã€‚è¿™ç§æƒ…å†µä»¥åŠæ„ŸæŸ“å¼•èµ·çš„åŒé£Ÿç—‡å¯¹è‚ é“èŒç¾¤çš„å½±å“æ˜¯å¦æ˜¯å‘¼å¸é“ç—…æ¯’æ„ŸæŸ“è¿‡ç¨‹ä¸­ä¿æŠ¤æ€§æŠ—ç‚ååº”çš„ä¸€éƒ¨åˆ†å°šæœ‰å¾…ç¡®å®šã€‚è‚ é“èŒç¾¤åœ¨å¥åº·å’Œç–¾ç—…ä¸­å…·æœ‰é‡è¦ä½œç”¨ï¼šè‚ é“ç»†èŒå¯ä»¥äº§ç”Ÿä»£è°¢äº§ç‰©ä¼šå…¨èº«æ€§æ”¹å˜å…ç–«ç»†èƒçš„åŠŸèƒ½ã€‚äº†è§£å¯èƒ½å¯¼è‡´è‚ é“å¾®ç”Ÿç‰©ç»„æ”¹å˜çš„å› ç´ å¯èƒ½æœ‰åŠ©äºä¸ºæ²»ç–—å¹²é¢„æä¾›ä¾æ®ã€‚è¿™æ˜¯ç¬¬ä¸€ä¸ªç³»ç»Ÿåœ°å‰–æä»ç—…æ¯’æ€§è‚ºéƒ¨æ„ŸæŸ“åˆ°è‚ é“èŒç¾¤å˜åŒ–çš„äº‹ä»¶é€”å¾„çš„ç ”ç©¶ã€‚æˆ‘ä»¬è¡¨æ˜ï¼Œå¯¹ç—…æ¯’æ€§è‚ºéƒ¨æ„ŸæŸ“çš„ç»†èƒå…ç–«ååº”ä¼šå¼•èµ·é£Ÿæ¬²ä¸æŒ¯ï¼Œè¿›è€Œæ”¹å˜è‚ é“å¾®ç”Ÿç‰©ç»„å’Œä»£è°¢ç»„ã€‚ä»¤äººæƒŠè®¶çš„æ˜¯ï¼Œä¸ç–¾ç—…æ¶ˆé€€ç›¸å…³çš„è„‚è´¨å¢åŠ ã€‚è¿™å¼€è¾Ÿäº†æ–°çš„ç ”ç©¶é€”å¾„ï¼šé¦–å…ˆï¼Œç”±Tç»†èƒäº§ç”Ÿçš„å¯è¯±å¯¼é£Ÿæ¬²ä¸æŒ¯çš„ï¼ˆå¯èƒ½æ˜¯åˆ†æ³Œçš„ï¼‰å› å­æ˜¯ä»€ä¹ˆï¼Ÿå…¶æ¬¡ï¼Œé£Ÿæ¬²ä¸æŒ¯æ˜¯ä¸€ç§èƒ½åŠ é€Ÿä»æ„ŸæŸ“ä¸­æ¢å¤çš„é€‚åº”ç—‡å—ï¼Ÿå¦‚æœæ˜¯ï¼Œå¾®ç”Ÿç‰©ç¾¤æ˜¯å¦åœ¨å…¶ä¸­èµ·ä½œç”¨ï¼Ÿ

[1m[33m####################################################################################################[0m

[1m[31mPubmed ID: 32265324[0m

title: Modulation of the Gut Microbiota during High-Dose Glycerol Monolaurate-Mediated Amelioration of Obesity in Mice Fed a High-Fat Diet [å–‚å…»é«˜è„‚é¥®é£Ÿçš„å¤§å‰‚é‡ç”˜æ²¹å•æœˆæ¡‚é…¸é…¯ä»‹å¯¼çš„è‚¥èƒ–æ”¹å–„è¿‡ç¨‹ä¸­è‚ é“èŒç¾¤çš„è°ƒèŠ‚]

doi: 10.1128/mBio.00190-20

link_url: https://pubmed.ncbi.nlm.nih.gov/32265324/

journal: mBio

date: 04/07/2020

enc_abstract: Obesity and associated metabolic disorders are worldwide public health issues. The gut microbiota plays a key role in the pathophysiology of diet-induced obesity. Glycerol monolaurate (GML) is a widely consumed food emulsifier with antibacterial properties. Here, we explore the anti-obesity effect of GML (1,600 mg/kg of body weight) in high-fat diet (HFD)-fed mice. HFD-fed mice were treated with 1,600 mg/kg GML. Integrated microbiome, metabolome, and transcriptome analyses were used to systematically investigate the metabolic effects of GML, and antibiotic treatment was used to assess the effects of GML on the gut microbiota. Our data indicated that GML significantly reduced body weight and visceral fat deposition, improved hyperlipidemia and hepatic lipid metabolism, and ameliorated glucose homeostasis and inflammation in HFD-fed mice. Importantly, GML modulated HFD-induced gut microbiota dysbiosis and selectively increased the abundance of Bifidobacterium pseudolongum Antibiotic treatment abolished all the GML-mediated metabolic improvements. A multiomics (microbiome, metabolome, and transcriptome) association study showed that GML significantly modulated glycerophospholipid metabolism, and the abundance of Bifidobacterium pseudolongum strongly correlated with the metabolites and genes that participated in glycerophospholipid metabolism. Our results indicated that GML may be provided for obesity prevention by targeting the gut microbiota and regulating glycerophospholipid metabolism.          

cn_abstract: è‚¥èƒ–ç—‡å’Œç›¸å…³çš„ä»£è°¢ç´Šä¹±æ˜¯å…¨ä¸–ç•Œçš„å…¬å…±å«ç”Ÿé—®é¢˜ã€‚è‚ é“èŒç¾¤åœ¨é¥®é£Ÿè¯±å¯¼çš„è‚¥èƒ–ç—‡çš„ç—…ç†ç”Ÿç†ä¸­èµ·ç€å…³é”®ä½œç”¨ã€‚ç”˜æ²¹å•æœˆæ¡‚é…¸é…¯ï¼ˆGMLï¼‰æ˜¯ä¸€ç§å¹¿æ³›ä½¿ç”¨çš„å…·æœ‰æŠ—èŒç‰¹æ€§çš„é£Ÿå“ä¹³åŒ–å‰‚ã€‚åœ¨è¿™é‡Œï¼Œæˆ‘ä»¬æ¢è®¨äº†GMLï¼ˆ1600 mg / kgä½“é‡ï¼‰åœ¨é«˜è„‚é¥®é£Ÿï¼ˆHFDï¼‰å–‚å…»çš„å°é¼ ä¸­çš„æŠ—è‚¥èƒ–ä½œç”¨ã€‚ç”¨HFDå–‚å…»çš„å°é¼ ç”¨1,600 mg / kg GMLæ²»ç–—ã€‚ç»¼åˆå¾®ç”Ÿç‰©ç»„ï¼Œä»£è°¢ç»„å’Œè½¬å½•ç»„åˆ†æç”¨äºç³»ç»Ÿåœ°ç ”ç©¶GMLçš„ä»£è°¢ä½œç”¨ï¼ŒæŠ—ç”Ÿç´ æ²»ç–—ç”¨äºè¯„ä¼°GMLå¯¹è‚ é“èŒç¾¤çš„å½±å“ã€‚æˆ‘ä»¬çš„æ•°æ®è¡¨æ˜GMLå¯ä»¥æ˜¾ç€é™ä½HFDå–‚å…»å°é¼ çš„ä½“é‡å’Œå†…è„è„‚è‚ªæ²‰ç§¯ï¼Œæ”¹å–„é«˜è„‚è¡€ç—‡å’Œè‚è„‚è´¨ä»£è°¢ï¼Œå¹¶æ”¹å–„è‘¡è„ç³–ç¨³æ€å’Œç‚ç—‡ã€‚é‡è¦çš„æ˜¯ï¼ŒGMLè°ƒèŠ‚äº†HFDè¯±å¯¼çš„è‚ é“èŒç¾¤å¤±è°ƒï¼Œå¹¶é€‰æ‹©æ€§åœ°å¢åŠ äº†å‡åŒæ­§åŒæ­§æ†èŒçš„ä¸°åº¦ã€‚æŠ—ç”Ÿç´ æ²»ç–—æ¶ˆé™¤äº†æ‰€æœ‰GMLä»‹å¯¼çš„ä»£è°¢æ”¹å–„ã€‚ä¸€é¡¹å¤šç»„å­¦ï¼ˆå¾®ç”Ÿç‰©ç»„ï¼Œä»£è°¢ç»„å’Œè½¬å½•ç»„ï¼‰å…³è”ç ”ç©¶è¡¨æ˜ï¼ŒGMLæ˜¾ç€è°ƒèŠ‚ç”˜æ²¹ç£·è„‚ä»£è°¢ï¼Œè€Œå‡é•¿åŒæ­§æ†èŒçš„ä¸°åº¦ä¸å‚ä¸ç”˜æ²¹ç£·è„‚ä»£è°¢çš„ä»£è°¢ç‰©å’ŒåŸºå› å¯†åˆ‡ç›¸å…³ã€‚æˆ‘ä»¬çš„ç»“æœè¡¨æ˜ï¼ŒGMLå¯é€šè¿‡é¶å‘è‚ é“èŒç¾¤å’Œè°ƒèŠ‚ç”˜æ²¹ç£·è„‚ä»£è°¢æ¥æä¾›é¢„é˜²è‚¥èƒ–çš„æ–¹æ³•ã€‚

[1m[33m####################################################################################################[0m

[1m[31mPubmed ID: 32317321[0m

title: Temporal Dynamics of the Adult Female Lower Urinary Tract Microbiota [æˆå¹´å¥³æ€§ä¸‹å°¿è·¯èŒç¾¤çš„æ—¶é—´åŠ¨æ€]

doi: 10.1128/mBio.00475-20

link_url: https://pubmed.ncbi.nlm.nih.gov/32317321/

journal: mBio

date: 04/21/2020

enc_abstract: Temporal dynamics of certain human microbiotas have been described in longitudinal studies; variability often relates to modifiable factors or behaviors. Early studies of the urinary microbiota preferentially used samples obtained by transurethral catheterization to minimize vulvovaginal microbial contributions. Whereas voided specimens are preferred for longitudinal studies, the few studies that reported longitudinal data were limited to women with lower urinary tract (LUT) symptoms, due to ease of accessing a clinical population for sampling and the impracticality and risk of collecting repeated catheterized urine specimens in a nonclinical population. Here, we studied the microbiota of the LUT of nonsymptomatic, premenopausal women using midstream voided urine (MSU) specimens to investigate relationships between microbial dynamics and personal factors. Using 16S rRNA gene sequencing and a metaculturomics method called expanded quantitative urine culture (EQUC), we characterized the microbiotas of MSU and periurethral swab specimens collected daily for approximately 3 months from a small cohort of adult women. Participants were screened for eligibility, including the ability to self-collect paired urogenital specimens prior to enrollment. In this population, we found that measures of microbial dynamics related to specific participant-reported factors, particularly menstruation and vaginal intercourse. Further investigation of the trends revealed differences in the composition and diversity of LUT microbiotas within and across participants. These data, in combination with previous studies showing relationships between the LUT microbiota and LUT symptoms, suggest that personal factors relating to the genitourinary system may be an important consideration in the etiology, prevention, and/or treatment of LUT disorders.IMPORTANCE Following the discovery of the collective human urinary microbiota, important knowledge gaps remain, including the stability and variability of this microbial niche over time. Initial urinary studies preferentially utilized samples obtained by transurethral catheterization to minimize contributions from vulvovaginal microbes. However, catheterization has the potential to alter the urinary microbiota; therefore, voided specimens are preferred for longitudinal studies. In this report, we describe microbial findings obtained by daily assessment over 3 months in a small cohort of adult women. We found that, similarly to vaginal microbiotas, lower urinary tract (LUT) microbiotas are dynamic, with changes relating to several factors, particularly menstruation and vaginal intercourse. Our study results show that LUT microbiotas are both dynamic and resilient. They also offer novel opportunities to target LUT microbiotas by preventative or therapeutic means, through risk and/or protective factor modification.          

cn_abstract: çºµå‘ç ”ç©¶å·²ç»æè¿°äº†æŸäº›äººç±»å¾®ç”Ÿç‰©çš„æ—¶é—´åŠ¨æ€ã€‚å¯å˜æ€§é€šå¸¸ä¸å¯ä¿®æ”¹çš„å› ç´ æˆ–è¡Œä¸ºæœ‰å…³ã€‚æ³Œå°¿å¾®ç”Ÿç‰©ç¾¤çš„æ—©æœŸç ”ç©¶ä¼˜å…ˆä½¿ç”¨ç»å°¿é“å¯¼ç®¡æ’å…¥æœ¯è·å¾—çš„æ ·æœ¬ï¼Œä»¥æœ€å¤§ç¨‹åº¦å‡å°‘å¤–é˜´é˜´é“å¾®ç”Ÿç‰©çš„å½±å“ã€‚å°½ç®¡ä½œç©ºæ´çš„æ ‡æœ¬é€‚åˆè¿›è¡Œçºµå‘ç ”ç©¶ï¼Œä½†å°‘æ•°æŠ¥å‘Šçºµå‘æ•°æ®çš„ç ”ç©¶ä»…é™äºå…·æœ‰ä¸‹å°¿è·¯ï¼ˆLUTï¼‰ç—‡çŠ¶çš„å¥³æ€§ï¼Œè¿™æ˜¯å› ä¸ºæ˜“äºè¿›å…¥ä¸´åºŠäººç¾¤è¿›è¡Œé‡‡æ ·ï¼Œå¹¶ä¸”ä¸å®ç”¨ä¸”æœ‰å¯èƒ½æ”¶é›†é‡å¤çš„å¯¼ç®¡å°¿æ¶²æ ‡æœ¬åœ¨éä¸´åºŠäººç¾¤ä¸­ã€‚åœ¨è¿™é‡Œï¼Œæˆ‘ä»¬ä½¿ç”¨ä¸­æ¸¸æ’å°¿ï¼ˆMSUï¼‰æ ‡æœ¬ç ”ç©¶äº†æ— ç—‡çŠ¶ï¼Œç»ç»å‰å¦‡å¥³LUTçš„å¾®ç”Ÿç‰©ç¾¤ï¼Œä»¥ç ”ç©¶å¾®ç”Ÿç‰©åŠ¨åŠ›å­¦ä¸ä¸ªäººå› ç´ ä¹‹é—´çš„å…³ç³»ã€‚æˆ‘ä»¬ä½¿ç”¨16S rRNAåŸºå› æµ‹åºå’Œä¸€ç§ç§°ä¸ºæ‰©å±•å®šé‡å°¿åŸ¹å…»ï¼ˆEQUCï¼‰çš„metaculturomicsæ–¹æ³•ï¼Œè¡¨å¾äº†æ¯å¤©ä»ä¸€ä¸ªæˆå¹´å¥³æ€§é˜Ÿåˆ—ä¸­æ”¶é›†çš„å¤§çº¦3ä¸ªæœˆä¸­æ¯å¤©æ”¶é›†çš„MSUå’Œå°¿é“å‘¨å›´æ‹­å­æ ‡æœ¬çš„å¾®ç”Ÿç‰©ç¾¤ã€‚ç­›é€‰å‚ä¸è€…çš„èµ„æ ¼ï¼ŒåŒ…æ‹¬åœ¨å…¥ç»„å‰è‡ªè¡Œæ”¶é›†é…å¯¹çš„æ³Œå°¿ç”Ÿæ®–å™¨æ ‡æœ¬çš„èƒ½åŠ›ã€‚åœ¨è¯¥äººç¾¤ä¸­ï¼Œæˆ‘ä»¬å‘ç°å¾®ç”Ÿç‰©åŠ¨åŠ›å­¦çš„æµ‹é‡ä¸ç‰¹å®šå‚ä¸è€…æŠ¥å‘Šçš„å› ç´ æœ‰å…³ï¼Œå°¤å…¶æ˜¯æœˆç»å’Œé˜´é“æ€§äº¤ã€‚å¯¹è¶‹åŠ¿çš„è¿›ä¸€æ­¥ç ”ç©¶æ­ç¤ºäº†å‚ä¸è€…å†…å’Œå‚ä¸è€…ä¹‹é—´LUTèŒç¾¤ç»„æˆå’Œå¤šæ ·æ€§çš„å·®å¼‚ã€‚è¿™äº›æ•°æ®ä¸å…ˆå‰çš„ç ”ç©¶æ˜¾ç¤ºLUTèŒç¾¤ä¸LUTç—‡çŠ¶ä¹‹é—´çš„å…³ç³»ç›¸ç»“åˆï¼Œè¡¨æ˜ä¸æ³Œå°¿ç”Ÿæ®–ç³»ç»Ÿæœ‰å…³çš„ä¸ªäººå› ç´ å¯èƒ½æ˜¯LUTç—…å› ï¼Œé¢„é˜²å’Œ/æˆ–æ²»ç–—ä¸­çš„é‡è¦è€ƒè™‘å› ç´ ã€‚åœ¨é›†ä½“äººç±»æ³Œå°¿å¾®ç”Ÿç‰©ç¾¤ä¸­ï¼Œé‡è¦çš„çŸ¥è¯†ç¼ºå£ä»ç„¶å­˜åœ¨ï¼ŒåŒ…æ‹¬è¯¥å¾®ç”Ÿç‰©ç”Ÿæ€ä½éšæ—¶é—´çš„ç¨³å®šæ€§å’Œå¯å˜æ€§ã€‚æœ€åˆçš„æ³Œå°¿ç ”ç©¶ä¼˜å…ˆåˆ©ç”¨ç»å°¿é“å¯¼ç®¡æ’å…¥æœ¯è·å¾—çš„æ ·æœ¬ï¼Œä»¥æœ€å¤§ç¨‹åº¦å‡å°‘å¤–é˜´é˜´é“å¾®ç”Ÿç‰©çš„è´¡çŒ®ã€‚ä½†æ˜¯ï¼Œå¯¼ç®¡æ’å…¥æœ¯å¯èƒ½ä¼šæ”¹å˜å°¿ä¸­çš„å¾®ç”Ÿç‰©ç¾¤ã€‚å› æ­¤ï¼Œæœ‰ç©ºéš™çš„æ ‡æœ¬æœ€å¥½ç”¨äºçºµå‘ç ”ç©¶ã€‚åœ¨æœ¬æŠ¥å‘Šä¸­ï¼Œæˆ‘ä»¬æè¿°äº†åœ¨ä¸€å°ç¾¤æˆå¹´å¥³æ€§ä¸­é€šè¿‡3ä¸ªæœˆçš„æ¯æ—¥è¯„ä¼°è·å¾—çš„å¾®ç”Ÿç‰©å‘ç°ã€‚æˆ‘ä»¬å‘ç°ï¼Œç±»ä¼¼äºé˜´é“å¾®ç”Ÿç‰©ç¾¤ï¼Œä¸‹æ³Œå°¿é“ï¼ˆLUTï¼‰å¾®ç”Ÿç‰©ç¾¤æ˜¯åŠ¨æ€çš„ï¼Œå…¶å˜åŒ–ä¸å¤šç§å› ç´ æœ‰å…³ï¼Œå°¤å…¶æ˜¯æœˆç»å’Œé˜´é“æ€§äº¤ã€‚æˆ‘ä»¬çš„ç ”ç©¶ç»“æœè¡¨æ˜ï¼ŒLUTèŒç¾¤æ—¢åŠ¨æ€åˆå¯Œæœ‰å¼¹æ€§ã€‚å®ƒä»¬è¿˜æä¾›äº†é€šè¿‡é¢„é˜²æˆ–æ²»ç–—æ‰‹æ®µï¼Œé€šè¿‡é£é™©å’Œ/æˆ–ä¿æŠ¤å› å­ä¿®é¥°æ¥é¶å‘LUTèŒç¾¤çš„æ–°æœºä¼šã€‚

[1m[33m####################################################################################################[0m

[1m[31mPubmed ID: 32457243[0m

title: Erratum for Cantu-Jungles and Hamaker, "New View on Dietary Fiber Selection for Predictable Shifts in Gut Microbiota" [Cantu-Jungleså’ŒHamakerçš„å‹˜è¯¯è¡¨ï¼Œâ€œé¥®é£Ÿçº¤ç»´é€‰æ‹©å¯¹è‚ é“èŒç¾¤å¯é¢„æµ‹å˜åŒ–çš„æ–°è§‚ç‚¹â€]

doi: 10.1128/mBio.00747-20

link_url: https://pubmed.ncbi.nlm.nih.gov/32457243/

journal: mBio

date: 05/26/2020

enc_abstract: No abstract

cn_abstract: æ²¡æœ‰æ‘˜è¦

[1m[33m####################################################################################################[0m

[1m[31mPubmed ID: 32487762[0m

title: Alterations in Vaginal Microbiota and Associated Metabolome in Women with Recurrent Implantation Failure [åå¤æ¤å…¥å¤±è´¥å¦‡å¥³çš„é˜´é“èŒç¾¤å’Œç›¸å…³ä»£è°¢ç»„çš„æ”¹å˜]

doi: 10.1128/mBio.03242-19

link_url: https://pubmed.ncbi.nlm.nih.gov/32487762/

journal: mBio

date: 06/02/2020

enc_abstract: Recurrent implantation failure (RIF) refers to repeated failure to become pregnant after transferring embryos with normal morphology. However, the pathogenesis of RIF remains unrevealed, especially for those without any pathological features. In this study, we characterized the vaginal microbiota and metabolomes of patients with unexplained RIF, while patients who achieved clinical pregnancy in the first frozen embryo transfer (FET) cycle were used as controls. Based on 16S rRNA gene sequencing of the vaginal microbiota, the vaginal Lactobacillus showed a significant positive correlation with the pregnancy rate, and the RIF group presented higher microbial Î±-diversity than the control group (P value = 0.016). The metabolomic profile identified 2,507 metabolites, of which 37 were significantly different between the two groups (P value < 0.05, variable importance for the projection [VIP] > 1). Among them, 2',3-cyclic UMP and inositol phosphate were the top two metabolites that were higher in the RIF group, while glycerophospholipids and benzopyran were important metabolites that were lower in the RIF group. A lack of lysobisphosphatidic acid and prostaglandin metabolized from glycerophospholipids will lead to deferred implantation and embryo crowding. Benzopyran, as a selective estrogen receptor modulator, may affect the outcome of pregnancy. All of the changes in metabolite profiles may result in or from the differential microbiota compositions in RIF patients. In conclusion, significant differences were presented in the vaginal microbiota and metabolomes between patients with unexplained RIF and women who became pregnant in the first FET cycle. For the first time, this study elaborates the possible pathogenesis of RIF by investigating the vaginal microbiota and metabolites in RIF patients.IMPORTANCE In vitro fertilization-embryo transfer (IVF-ET) is now widely applied for treating infertility, and unexplained recurrent implantation failure (RIF) has become a substantial challenge. We hypothesize that vaginal microbial dysbiosis is associated with RIF, as it is linked to many female reproductive diseases. In this study, we characterized the vaginal microbiota and metabolomes of patients with unexplained RIF, while patients who achieved clinical pregnancy in the first IVF cycle were set as controls. In general, significant differences were discovered in the vaginal microbiota and metabolomes between the two groups. This study is the first detailed elaboration of the vaginal microbiota and metabolites associated with RIF. We believe that our findings will inspire researchers to consider the dynamics of microbiomes related to the microenvironment as a critical feature for future studies of nosogenesis not only for RIF but also for other reproductive diseases.          

cn_abstract: åå¤æ¤å…¥å¤±è´¥ï¼ˆRIFï¼‰æ˜¯æŒ‡åœ¨è½¬ç§»å…·æœ‰æ­£å¸¸å½¢æ€çš„èƒšèƒååå¤æ— æ³•æ€€å­•ã€‚ä½†æ˜¯ï¼ŒRIFçš„å‘ç—…æœºåˆ¶ä»ç„¶æ²¡æœ‰å‘ç°ï¼Œç‰¹åˆ«æ˜¯å¯¹äºé‚£äº›æ²¡æœ‰ä»»ä½•ç—…ç†ç‰¹å¾çš„äººã€‚åœ¨è¿™é¡¹ç ”ç©¶ä¸­ï¼Œæˆ‘ä»¬è¡¨å¾äº†æ— æ³•è§£é‡Šçš„RIFæ‚£è€…çš„é˜´é“å¾®ç”Ÿç‰©ç¾¤å’Œä»£è°¢ç»„ï¼Œè€Œåœ¨ç¬¬ä¸€ä¸ªå†·å†»èƒšèƒç§»æ¤ï¼ˆFETï¼‰å‘¨æœŸä¸­è·å¾—ä¸´åºŠå¦Šå¨ çš„æ‚£è€…è¢«ç”¨ä½œå¯¹ç…§ã€‚æ ¹æ®é˜´é“èŒç¾¤çš„16S rRNAåŸºå› æµ‹åºï¼Œé˜´é“ä¹³é…¸æ†èŒä¸å¦Šå¨ ç‡å‘ˆæ˜¾ç€æ­£ç›¸å…³ï¼ŒRIFç»„çš„å¾®ç”Ÿç‰©Î±å¤šæ ·æ€§é«˜äºå¯¹ç…§ç»„ï¼ˆPå€¼= 0.016ï¼‰ã€‚ä»£è°¢ç»„å­¦ç‰¹å¾ç¡®å®šäº†2,507ç§ä»£è°¢ç‰©ï¼Œå…¶ä¸­ä¸¤ç»„ä¹‹é—´æœ‰37ç§æ˜¾ç€ä¸åŒï¼ˆPå€¼<0.05ï¼Œé¢„æµ‹çš„é‡è¦ç¨‹åº¦[VIP]> 1ï¼‰ã€‚å…¶ä¸­ï¼ŒRIFç»„ä¸­2'ï¼Œ3-ç¯UMPå’Œè‚Œé†‡ç£·é…¸æ˜¯æœ€é«˜çš„ä¸¤ä¸ªä»£è°¢äº§ç‰©ï¼Œè€Œç”˜æ²¹è„‚å’Œè‹¯å¹¶å¡å–ƒæ˜¯RIFç»„ä¸­è¾ƒä½çš„é‡è¦ä»£è°¢äº§ç‰©ã€‚ç¼ºä¹ä»ç”˜æ²¹ç£·è„‚ä»£è°¢çš„æº¶è¡€åŒç£·è„‚é…¸å’Œå‰åˆ—è…ºç´ ä¼šå¯¼è‡´æ¨è¿Ÿæ¤å…¥å’Œèƒšèƒæ‹¥æŒ¤ã€‚è‹¯å¹¶å¡å–ƒä½œä¸ºé€‰æ‹©æ€§é›Œæ¿€ç´ å—ä½“è°ƒèŠ‚å‰‚ï¼Œå¯èƒ½ä¼šå½±å“å¦Šå¨ ç»“å±€ã€‚ RIFæ‚£è€…ä½“å†…ä»£è°¢ç‰©è°±çš„æ‰€æœ‰å˜åŒ–éƒ½å¯èƒ½å¯¼è‡´å¾®ç”Ÿç‰©ç¾¤ç»„æˆçš„å·®å¼‚æˆ–ç”±å¾®ç”Ÿç‰©ç¾¤ç»„æˆçš„å·®å¼‚å¼•èµ·ã€‚æ€»ä¹‹ï¼Œåœ¨æ— æ³•è§£é‡Šçš„RIFæ‚£è€…å’Œåœ¨ç¬¬ä¸€ä¸ªFETå‘¨æœŸä¸­æ€€å­•çš„å¦‡å¥³ä¹‹é—´ï¼Œé˜´é“å¾®ç”Ÿç‰©ç¾¤å’Œä»£è°¢ç»„å­˜åœ¨æ˜¾ç€å·®å¼‚ã€‚è¿™é¡¹ç ”ç©¶é¦–æ¬¡é€šè¿‡ç ”ç©¶RIFæ‚£è€…çš„é˜´é“å¾®ç”Ÿç‰©ç¾¤å’Œä»£è°¢äº§ç‰©æ¥é˜æ˜RIFçš„å¯èƒ½å‘ç—…æœºç†ã€‚ RIFï¼‰å·²æˆä¸ºä¸€é¡¹é‡å¤§æŒ‘æˆ˜ã€‚æˆ‘ä»¬å‡è®¾é˜´é“å¾®ç”Ÿç‰©è¥å…»ä¸è‰¯ä¸RIFæœ‰å…³ï¼Œå› ä¸ºå®ƒä¸è®¸å¤šå¥³æ€§ç”Ÿæ®–ç–¾ç—…æœ‰å…³ã€‚åœ¨è¿™é¡¹ç ”ç©¶ä¸­ï¼Œæˆ‘ä»¬è¡¨å¾äº†æ— æ³•è§£é‡Šçš„RIFæ‚£è€…çš„é˜´é“å¾®ç”Ÿç‰©ç¾¤å’Œä»£è°¢ç»„ï¼ŒåŒæ—¶å°†åœ¨ç¬¬ä¸€ä¸ªIVFå‘¨æœŸä¸­è·å¾—ä¸´åºŠå¦Šå¨ çš„æ‚£è€…ä½œä¸ºå¯¹ç…§ã€‚é€šå¸¸ï¼Œä¸¤ç»„ä¹‹é—´çš„é˜´é“å¾®ç”Ÿç‰©ç¾¤å’Œä»£è°¢ç»„ä¹‹é—´å­˜åœ¨æ˜¾ç€å·®å¼‚ã€‚è¿™é¡¹ç ”ç©¶æ˜¯é¦–æ¬¡è¯¦ç»†é˜è¿°ä¸RIFç›¸å…³çš„é˜´é“å¾®ç”Ÿç‰©ç¾¤å’Œä»£è°¢äº§ç‰©ã€‚æˆ‘ä»¬ç›¸ä¿¡ï¼Œæˆ‘ä»¬çš„å‘ç°å°†æ¿€å‘ç ”ç©¶äººå‘˜å°†ä¸å¾®ç¯å¢ƒæœ‰å…³çš„å¾®ç”Ÿç‰©ç»„çš„åŠ¨åŠ›å­¦è§†ä¸ºæœªæ¥ç ”ç©¶è‡´æ­»ç°è±¡çš„é‡è¦ç‰¹å¾ï¼Œä¸ä»…é’ˆå¯¹RIFï¼Œè€Œä¸”è¿˜é’ˆå¯¹å…¶ä»–ç”Ÿæ®–ç–¾ç—…ã€‚

[1m[33m####################################################################################################[0m

[1m[31mPubmed ID: 32525754[0m

title: Cytotoxin-producing Klebsiella oxytoca in the preterm gut and its association with necrotizing enterocolitis [æ—©äº§è‚ ä¸­äº§ç”Ÿç»†èƒæ¯’ç´ çš„äº§é…¸å…‹é›·ä¼¯èŒåŠå…¶ä¸åæ­»æ€§å°è‚ ç»“è‚ ç‚çš„å…³ç³»]

doi: 10.1080/22221751.2020.1773743

link_url: https://pubmed.ncbi.nlm.nih.gov/32525754/

journal: Emerg Microbes Infect

date: 2020 Dec

enc_abstract: Necrotizing enterocolitis (NEC) is a devastating intestinal inflammatory disease of premature infants associated with gut bacterial dysbiosis. Using 16S rRNA-based methods, our laboratory identified an unclassified Enterobacteriaceae sequence (NEC_unk_OTU) with high abundance in NEC fecal samples. We aimed to identify this bacterium and determine its potential role in the disease. NCBI database searches for the 16S sequence, selective culture systems, biotyping and polymerase chain reaction were employed to refine classification of NEC_unk_OTU and identify toxin-encoding genes from the index NEC case. Bacterial cytotoxin production was confirmed by mass spectrometry and apoptosis assays. Additional fecal samples from 9 NEC and 5 non-NEC controls were analyzed using similar methods and multi-locus sequence typing (MLST) was performed to investigate clonal relationships and define sequence types of the isolates. NEC_unk_OTU was identified as Klebsiella oxytoca, a pathobiont known to cause antibiotic-associated hemorrhagic colitis, but not previously linked to NEC. Including the index case, cytotoxin-producing strains of K. oxytoca were isolated from 6 of 10 subjects with NEC; in these, the K. oxytoca 16S sequence predominated the fecal microbiota. Cytotoxin-producing strains of K. oxytoca also were isolated from 4 of 5 controls; in these, however, the abundance of the corresponding 16S sequence was very low. MLST analysis of the toxin-positive isolates demonstrated no clonal relationships and similar genetic clustering between cases and controls. These results suggest cytotoxin-producing strains of K. oxytoca colonize a substantial proportion of premature infants. Some, perhaps many, cases of NEC may be precipitated by outgrowth of this opportunistic pathogen.          

cn_abstract: åæ­»æ€§å°è‚ ç»“è‚ ç‚ï¼ˆNECï¼‰æ˜¯ä¸è‚ é“ç»†èŒæ€§è¥å…»ä¸è‰¯ç›¸å…³çš„æ—©äº§å„¿çš„æ¯ç­æ€§è‚ ç‚æ€§ç–¾ç—…ã€‚ä½¿ç”¨åŸºäº16S rRNAçš„æ–¹æ³•ï¼Œæˆ‘ä»¬çš„å®éªŒå®¤åœ¨NECç²ªä¾¿æ ·å“ä¸­é‰´å®šäº†ä¸€ä¸ªé«˜ä¸°åº¦çš„æœªåˆ†ç±»è‚ æ†èŒç§‘åºåˆ—ï¼ˆNEC_unk_OTUï¼‰ã€‚æˆ‘ä»¬æ—¨åœ¨é‰´å®šè¿™ç§ç»†èŒå¹¶ç¡®å®šå…¶åœ¨ç–¾ç—…ä¸­çš„æ½œåœ¨ä½œç”¨ã€‚é€šè¿‡NCBIæ•°æ®åº“æœç´¢16Såºåˆ—ï¼Œé€‰æ‹©åŸ¹å…»ç³»ç»Ÿï¼Œç”Ÿç‰©åˆ†å‹å’Œèšåˆé…¶é“¾ååº”æ¥å®Œå–„NEC_unk_OTUçš„åˆ†ç±»å¹¶ä»NECç—…ä¾‹ä¸­é‰´å®šå‡ºæ¯’ç´ ç¼–ç åŸºå› ã€‚è´¨è°±å’Œå‡‹äº¡åˆ†æè¯å®äº†ç»†èŒç»†èƒæ¯’ç´ çš„äº§ç”Ÿã€‚ä½¿ç”¨ç±»ä¼¼æ–¹æ³•åˆ†æäº†æ¥è‡ª9ä¸ªNECå’Œ5ä¸ªéNECå¯¹ç…§çš„å…¶ä»–ç²ªä¾¿æ ·æœ¬ï¼Œå¹¶è¿›è¡Œäº†å¤šä½ç‚¹åºåˆ—åˆ†å‹ï¼ˆMLSTï¼‰ï¼Œä»¥ç ”ç©¶å…‹éš†å…³ç³»å¹¶ç¡®å®šåˆ†ç¦»æ ªçš„åºåˆ—ç±»å‹ã€‚ NEC_unk_OTUè¢«é‰´å®šä¸ºäº§é…¸å…‹é›·ä¼¯èŒï¼Œå·²çŸ¥å¯å¼•èµ·æŠ—ç”Ÿç´ ç›¸å…³çš„å‡ºè¡€æ€§ç»“è‚ ç‚ï¼Œä½†ä»¥å‰æœªä¸NECç›¸å…³ã€‚åŒ…æ‹¬ç´¢å¼•ç—…ä¾‹åœ¨å†…ï¼Œä»10ä¾‹NECå—è¯•è€…ä¸­åˆ†ç¦»å‡º6ä¾‹äº§äº§äº§æ°§åˆæ†èŒçš„èŒæ ªã€‚åœ¨è¿™äº›ä¸­ï¼Œå‚¬äº§å…‹é›·ä¼¯æ°èŒ16Såºåˆ—å æ®äº†ç²ªä¾¿å¾®ç”Ÿç‰©ç¾¤çš„å¤§éƒ¨åˆ†ã€‚è¿˜ä»5ä¸ªå¯¹ç…§ä¸­çš„4ä¸ªä¸­åˆ†ç¦»å‡ºäº§äº§äº§æ°§åŒ–æ¯’ç´ çš„äº§é…¸å…‹é²ç»´é…µæ¯èŒæ ªã€‚ä½†æ˜¯ï¼Œåœ¨è¿™äº›åºåˆ—ä¸­ï¼Œç›¸åº”çš„16Såºåˆ—çš„ä¸°åº¦éå¸¸ä½ã€‚æ¯’ç´ é˜³æ€§åˆ†ç¦»ç‰©çš„MLSTåˆ†æè¡¨æ˜ï¼Œç—…ä¾‹ä¸å¯¹ç…§ä¹‹é—´æ— å…‹éš†å…³ç³»å’Œç›¸ä¼¼çš„é—ä¼ èšç±»ã€‚è¿™äº›ç»“æœè¡¨æ˜ï¼Œäº§äº§äº§æ¯’ç´ çš„äº§æ°§å‡ä¸é…µæ¯èŒæ ªå®šå±…åœ¨å¤§éƒ¨åˆ†æ—©äº§å„¿ä¸­ã€‚è¿™ç§æœºä¼šç—…åŸä½“çš„ç”Ÿé•¿å¯èƒ½ä¼šå¯¼è‡´ä¸€äº›ï¼ˆä¹Ÿè®¸å¾ˆå¤šï¼‰NECç—…ä¾‹ã€‚

[1m[33m####################################################################################################[0m

[1m[31mPubmed ID: 32552447[0m

title: Metagenomic analysis of the lung microbiome in pulmonary tuberculosis - a pilot study [è‚ºç»“æ ¸ä¸­è‚ºå¾®ç”Ÿç‰©ç»„çš„å…ƒåŸºå› ç»„åˆ†æ-ä¸€é¡¹åˆæ­¥ç ”ç©¶]

doi: 10.1080/22221751.2020.1783188

link_url: https://pubmed.ncbi.nlm.nih.gov/32552447/

journal: Emerg Microbes Infect

date: 2020 Dec

enc_abstract: The lung microbiome plays an important role in the pathophysiological processes associated with pulmonary tuberculosis (PTB). However, only a few studies using 16S rDNA amplicon sequencing have been reported, and the interactions between Mycobacterium tuberculosis (MTB) and the lung microbiome remain poorly understood. Patients with respiratory symptoms and imaging abnormalities compatible with tuberculosis (TB) were enrolled. We analyzed the lung microbiome in bronchoalveolar lavage (BAL) samples from 30 MTB-positive (MTB+) subjects and 30 MTB negative (MTB-) subjects by shotgun metagenomic sequencing. Alpha diversity tended to be lower in the MTB+ group than in the MTB- group. There was a significant difference in beta diversity between the MTB+ and MTB- subjects. MTB+ lung samples were dominated by MTB, while MTB- samples were enriched with Streptococcus, Prevotella, Nesseria, Selenomonas and Bifidobacterium, which more closely resemble the microbial composition of a healthy lung. Network analysis suggested that MTB could greatly impact the microbial community structure. MTB+ and MTB- communities showed distinct functional signatures. Fungal communities were also found to be associated with the presence or absence of MTB. Furthermore, it was confirmed that 16S rDNA amplicon sequencing underrepresents Mycobacterium. This pilot study is the first to explore the interplay between MTB and the host microbiome by using metagenomic sequencing. MTB dominates the lung microbiome of MTB+ subjects, while MTB- subjects have a Streptococcus-enriched microbiome. The 16S approach underrepresents Mycobacterium and is not the best way to study the TB-associated microbiome.          

cn_abstract: è‚ºå¾®ç”Ÿç‰©ç»„åœ¨ä¸è‚ºç»“æ ¸ï¼ˆPTBï¼‰ç›¸å…³çš„ç—…ç†ç”Ÿç†è¿‡ç¨‹ä¸­èµ·ç€é‡è¦ä½œç”¨ã€‚ä½†æ˜¯ï¼Œä»…æŠ¥é“äº†å°‘æ•°ä½¿ç”¨16S rDNAæ‰©å¢å­æµ‹åºçš„ç ”ç©¶ï¼Œè€Œç»“æ ¸åˆ†ææ†èŒï¼ˆMTBï¼‰ä¸è‚ºå¾®ç”Ÿç‰©ç»„ä¹‹é—´çš„ç›¸äº’ä½œç”¨ä»ç„¶çŸ¥ä¹‹ç”šå°‘ã€‚çº³å…¥å‘¼å¸ç³»ç»Ÿç—‡çŠ¶å’Œå½±åƒå­¦å¼‚å¸¸ä¸ç»“æ ¸ç—…ï¼ˆTBï¼‰ç›¸å®¹çš„æ‚£è€…ã€‚æˆ‘ä»¬é€šè¿‡æ•£å¼¹æªå®åŸºå› ç»„æµ‹åºå¯¹æ¥è‡ª30åMTBé˜³æ€§ï¼ˆMTB +ï¼‰å—è¯•è€…å’Œ30åMTBé˜´æ€§ï¼ˆMTB-ï¼‰å—è¯•è€…çš„æ”¯æ°”ç®¡è‚ºæ³¡çŒæ´—ï¼ˆBALï¼‰æ ·å“ä¸­çš„è‚ºå¾®ç”Ÿç‰©ç»„è¿›è¡Œäº†åˆ†æã€‚ MTB +ç»„çš„Alphaå¤šæ ·æ€§å¾€å¾€ä½äºMTB-ç»„ã€‚åœ¨MTB +å’ŒMTB-å—è¯•è€…ä¹‹é—´ï¼ŒÎ²å¤šæ ·æ€§å­˜åœ¨æ˜¾ç€å·®å¼‚ã€‚ MTB +è‚ºæ ·å“ä»¥MTBä¸ºä¸»ï¼Œè€ŒMTB-æ ·å“ä¸­å¯Œå«é“¾çƒèŒï¼Œæ™®æ°æ†èŒï¼Œå¥ˆç‘ŸèŒï¼Œç¡’å•èƒèŒå’ŒåŒæ­§æ†èŒï¼Œå®ƒä»¬æ›´ç±»ä¼¼äºå¥åº·è‚ºçš„å¾®ç”Ÿç‰©ç»„æˆã€‚ç½‘ç»œåˆ†æè¡¨æ˜ï¼ŒMTBå¯èƒ½ä¼šæå¤§åœ°å½±å“å¾®ç”Ÿç‰©ç¾¤è½ç»“æ„ã€‚ MTB +å’ŒMTB-ç¤¾åŒºæ˜¾ç¤ºå‡ºä¸åŒçš„åŠŸèƒ½ç‰¹å¾ã€‚è¿˜å‘ç°çœŸèŒç¾¤è½ä¸MTBçš„å­˜åœ¨ä¸å¦æœ‰å…³ã€‚æ­¤å¤–ï¼Œè¯å®äº†16S rDNAæ‰©å¢å­æµ‹åºä¸è¶³ä»£è¡¨äº†åˆ†ææ†èŒã€‚è¯¥åˆæ­¥ç ”ç©¶æ˜¯ç¬¬ä¸€ä¸ªé€šè¿‡ä½¿ç”¨å®åŸºå› ç»„æµ‹åºæ¢ç´¢MTBä¸å®¿ä¸»å¾®ç”Ÿç‰©ç»„ä¹‹é—´ç›¸äº’ä½œç”¨çš„ç ”ç©¶ã€‚ MTBåœ¨MTB +å—è¯•è€…çš„è‚ºå¾®ç”Ÿç‰©ç»„ä¸­å ä¸»å¯¼åœ°ä½ï¼Œè€ŒMTB-å—è¯•è€…å…·æœ‰é“¾çƒèŒå¯Œé›†çš„å¾®ç”Ÿç‰©ç»„ã€‚ 16Sæ–¹æ³•ä¸è¶³ä»¥ä»£è¡¨åˆ†ææ†èŒï¼Œä¹Ÿä¸æ˜¯ç ”ç©¶ç»“æ ¸ç—…ç›¸å…³å¾®ç”Ÿç‰©ç»„çš„æœ€ä½³æ–¹æ³•ã€‚

[1m[33m####################################################################################################[0m

[1m[31mPubmed ID: 32615913[0m

title: Longitudinal gut microbiome changes in alcohol use disorder are influenced by abstinence and drinking quantity [æˆ’é…’å’Œé¥®é…’é‡ä¼šå½±å“é…’ç²¾ä½¿ç”¨éšœç¢çš„çºµå‘è‚ é“å¾®ç”Ÿç‰©ç»„å˜åŒ–]

doi: 10.1080/19490976.2020.1758010

link_url: https://pubmed.ncbi.nlm.nih.gov/32615913/

journal: Gut Microbes

date: 11/01/2020

enc_abstract: Many patients with alcohol use disorder (AUD) consume alcohol chronically and in large amounts that alter intestinal microbiota, damage the gastrointestinal tract, and thereby injure other organs via malabsorption and intestinal inflammation. We hypothesized that alcohol consumption and subsequent abstinence would change the gut microbiome in adults admitted to a treatment program. Stool and oral specimens, diet data, gastrointestinal assessment scores, anxiety, depression measures and drinking amounts were collected longitudinally for up to 4 weeks in 22 newly abstinent inpatients with AUD who were dichotomized as less heavy drinkers (LHD, <10 drinks/d) and very heavy drinkers (VHD, 10 or more drinks/d). Next-generation 16 S rRNA gene sequencing was performed to measure the gut and oral microbiome at up to ten time points/subject and LHD and VHD were compared for change in principal components, Shannon diversity index and specific genera. The first three principal components explained 46.7% of the variance in gut microbiome diversity across time and all study subjects, indicating the change in gut microbiome following abstinence. The first time point was an outlier in three-dimensional principal component space versus all other time points. The gut microbiota in LHD and VHD were significantly dissimilar in change from day 1 to day 5 (p = .03) and from day 1 to week 3 (p = .02). The VHD drinking group displayed greater change from baseline. The Shannon diversity index of the gut microbiome changed significantly during abstinence in five participants. In both groups, the Shannon diversity was lower in the oral microbiome than gut. Ten total genera were shared between oral and stool in the AUD participants. These data were compared with healthy controls from the Human Microbiome Project to investigate the concept of a core microbiome. Rapid changes in gut microbiome following abstinence from alcohol suggest resilience of the gut microbiome in AUD and reflects the benefits of refraining from the highest levels of alcohol and potential benefits of abstinence.          

cn_abstract: è®¸å¤šæ‚£æœ‰é…’ç²¾ä½¿ç”¨éšœç¢ï¼ˆAUDï¼‰çš„æ‚£è€…é•¿æœŸå¤§é‡é¥®é…’ï¼Œä»è€Œæ”¹å˜è‚ é“èŒç¾¤ï¼ŒæŸå®³èƒƒè‚ é“ï¼Œä»è€Œé€šè¿‡å¸æ”¶ä¸è‰¯å’Œè‚ é“ç‚ç—‡ä¼¤å®³å…¶ä»–å™¨å®˜ã€‚æˆ‘ä»¬å‡è®¾é¥®é…’å’Œéšåçš„æˆ’é…’ä¼šæ”¹å˜æ¥å—æ²»ç–—æ–¹æ¡ˆçš„æˆå¹´äººçš„è‚ é“å¾®ç”Ÿç‰©ç»„ã€‚çºµå‘æ”¶é›†äº†22ååˆšæˆ’æ–­çš„AUDä½é™¢æ‚£è€…çš„ç²ªä¾¿å’Œå£è…”æ ‡æœ¬ï¼Œé¥®é£Ÿæ•°æ®ï¼Œèƒƒè‚ é“è¯„ä¼°è¯„åˆ†ï¼Œç„¦è™‘ï¼ŒæŠ‘éƒé‡åº¦å’Œé¥®é…’é‡ï¼Œé•¿è¾¾4å‘¨ï¼Œè¿™äº›æ‚£è€…è¢«åˆ†ä¸ºè½»åº¦é¥®é…’è€…ï¼ˆLHDï¼Œ<10æ¯/å¤©ï¼‰å’Œéå¸¸æ²‰é‡çš„é¥®é…’è€…ï¼ˆVHDï¼Œæ¯å¤©å–10æ¯æˆ–æ›´å¤šï¼‰ã€‚è¿›è¡Œäº†ä¸‹ä¸€ä»£16 S rRNAåŸºå› æµ‹åºï¼Œä»¥æµ‹é‡è‚ é“å’Œå£è…”å¾®ç”Ÿç‰©ç»„çš„å¤šè¾¾10ä¸ªæ—¶é—´ç‚¹/å—è¯•è€…ï¼Œå¹¶æ¯”è¾ƒäº†LHDå’ŒVHDçš„ä¸»è¦æˆåˆ†ï¼Œé¦™å†œå¤šæ ·æ€§æŒ‡æ•°å’Œç‰¹å®šå±çš„å˜åŒ–ã€‚å‰ä¸‰ä¸ªä¸»è¦æˆåˆ†è§£é‡Šäº†æ•´ä¸ªæ—¶é—´æ®µå’Œæ‰€æœ‰ç ”ç©¶å¯¹è±¡çš„è‚ é“å¾®ç”Ÿç‰©ç»„å¤šæ ·æ€§çš„46.7ï¼…çš„å˜åŒ–ï¼Œè¡¨æ˜ç¦æ¬²åè‚ é“å¾®ç”Ÿç‰©ç»„çš„å˜åŒ–ã€‚ç¬¬ä¸€ä¸ªæ—¶é—´ç‚¹æ˜¯ä¸‰ç»´ä¸»æˆåˆ†ç©ºé—´ä¸æ‰€æœ‰å…¶ä»–æ—¶é—´ç‚¹çš„ç¦»ç¾¤å€¼ã€‚ä»ç¬¬1å¤©åˆ°ç¬¬5å¤©ï¼ˆp = .03ï¼‰å’Œä»ç¬¬1å¤©åˆ°ç¬¬3å‘¨ï¼ˆp = .02ï¼‰ï¼ŒLHDå’ŒVHDä¸­çš„è‚ é“èŒç¾¤å˜åŒ–æ˜¾ç€ä¸åŒã€‚ VHDé¥®é…’ç»„ä¸åŸºçº¿ç›¸æ¯”æ˜¾ç¤ºå‡ºæ›´å¤§çš„å˜åŒ–ã€‚åœ¨äº”ä½å‚ä¸è€…çš„èŠ‚åˆ¶æœŸé—´ï¼Œè‚ é“å¾®ç”Ÿç‰©ç»„çš„é¦™å†œå¤šæ ·æ€§æŒ‡æ•°å‘ç”Ÿäº†æ˜¾ç€å˜åŒ–ã€‚åœ¨ä¸¤ç»„ä¸­ï¼Œå£è…”å¾®ç”Ÿç‰©ç»„çš„é¦™å†œå¤šæ ·æ€§å‡ä½äºè‚ é“ã€‚ AUDå‚åŠ è€…çš„å£è…”å’Œç²ªä¾¿å…±æœ‰10ä¸ªå±ã€‚å°†è¿™äº›æ•°æ®ä¸äººç±»å¾®ç”Ÿç‰©ç»„è®¡åˆ’çš„å¥åº·å¯¹ç…§è¿›è¡Œæ¯”è¾ƒï¼Œä»¥ç ”ç©¶æ ¸å¿ƒå¾®ç”Ÿç‰©ç»„çš„æ¦‚å¿µã€‚æˆ’é…’åè‚ é“å¾®ç”Ÿç‰©ç»„çš„å¿«é€Ÿå˜åŒ–è¡¨æ˜è‚ é“å¾®ç”Ÿç‰©ç»„åœ¨æ¾³å…ƒä¸­å…·æœ‰å¤åŸåŠ›ï¼Œåæ˜ å‡ºæˆ’é™¤é…’ç²¾å«é‡æœ€é«˜çš„å¥½å¤„ä»¥åŠæˆ’é…’çš„æ½œåœ¨å¥½å¤„ã€‚

[1m[33m####################################################################################################[0m

[1m[31mPubmed ID: 32638560[0m

title: Diagnostic Models for Atopic Dermatitis Based on Serum Microbial Extracellular Vesicle Metagenomic Analysis: A Pilot Study [åŸºäºè¡€æ¸…å¾®ç”Ÿç‰©ç»†èƒå¤–å›Šæ³¡åŸºå› ç»„å­¦åˆ†æçš„ç‰¹åº”æ€§çš®ç‚çš„è¯Šæ–­æ¨¡å‹ï¼šä¸€é¡¹åˆæ­¥ç ”ç©¶]

doi: 10.4168/aair.2020.12.5.792

link_url: https://pubmed.ncbi.nlm.nih.gov/32638560/

journal: Allergy Asthma Immunol Res

date: 2020 Sep

enc_abstract: Purpose:                    Associations between a wide variety of diseases and the microbiome have been extensively verified. Recently, there has been a rising interest in the role the microbiome plays in atopic dermatitis (AD). Furthermore, metagenomic analysis of microbe-derived extracellular vesicles (EVs) has revealed the importance and relevance of microbial EVs in human health.          

cn_abstract: ç›®çš„ï¼šå·²ç»å¹¿æ³›è¯å®äº†å¤šç§ç–¾ç—…ä¸å¾®ç”Ÿç‰©ç»„ä¹‹é—´çš„å…³è”ã€‚æœ€è¿‘ï¼Œäººä»¬å¯¹å¾®ç”Ÿç‰©ç»„åœ¨ç‰¹åº”æ€§çš®ç‚ï¼ˆADï¼‰ä¸­çš„ä½œç”¨è¶Šæ¥è¶Šæ„Ÿå…´è¶£ã€‚æ­¤å¤–ï¼Œå¯¹æºè‡ªå¾®ç”Ÿç‰©çš„ç»†èƒå¤–å›Šæ³¡ï¼ˆEVï¼‰çš„å®åŸºå› ç»„å­¦åˆ†æå·²æ­ç¤ºäº†å¾®ç”Ÿç‰©EVåœ¨äººç±»å¥åº·ä¸­çš„é‡è¦æ€§å’Œç›¸å…³æ€§ã€‚

[1m[33m####################################################################################################[0m

[1m[31mPubmed ID: 32640120[0m

title: Generation of Complete Multi-Cell Type Lung Organoids From Human Embryonic and Patient-Specific Induced Pluripotent Stem Cells for Infectious Disease Modeling and Therapeutics Validation [ä»äººç±»èƒšèƒå’Œæ‚£è€…ç‰¹å¼‚æ€§è¯±å¯¼å¤šèƒ½å¹²ç»†èƒç”Ÿæˆå®Œæ•´çš„å¤šç»†èƒå‹è‚ºç±»å™¨å®˜ï¼Œä»¥è¿›è¡Œä¼ æŸ“ç—…å»ºæ¨¡å’Œæ²»ç–—éªŒè¯]

doi: 10.1002/cpsc.118

link_url: https://pubmed.ncbi.nlm.nih.gov/32640120/

journal: Curr Protoc Stem Cell Biol

date: 2020 Sep

enc_abstract: The normal development of the pulmonary system is critical to transitioning from placental-dependent fetal life to alveolar-dependent newborn life. Human lung development and disease have been difficult to study due to the lack of an in vitro model system containing cells from the large airways and distal alveolus. This article describes a system that allows human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs) to differentiate and form three-dimensional (3D) structures that emulate the development, cytoarchitecture, and function of the lung ("organoids"), containing epithelial and mesenchymal cell populations, and including the production of surfactant and presence of ciliated cells. The organoids can also be invested with mesoderm derivatives, differentiated from the same human pluripotent stem cells, such as alveolar macrophages and vasculature. Such lung organoids may be used to study the impact of environmental modifiers and perturbagens (toxins, microbial or viral pathogens, alterations in microbiome) or the efficacy and safety of drugs, biologics, and gene transfer. Â© 2020 Wiley Periodicals LLC. Basic Protocol: hESC/hiPSC dissection, definitive endoderm formation, and lung progenitor cell induction.          

cn_abstract: è‚ºç³»ç»Ÿçš„æ­£å¸¸å‘è‚²å¯¹äºä»ä¾èµ–èƒç›˜çš„èƒå„¿ç”Ÿå‘½è¿‡æ¸¡åˆ°ä¾èµ–è‚ºæ³¡çš„æ–°ç”Ÿå„¿ç”Ÿå‘½è‡³å…³é‡è¦ã€‚ç”±äºç¼ºä¹åŒ…å«å¤§æ°”é“å’Œè¿œç«¯è‚ºæ³¡ç»†èƒçš„ä½“å¤–æ¨¡å‹ç³»ç»Ÿï¼Œå› æ­¤éš¾ä»¥ç ”ç©¶äººçš„è‚ºéƒ¨å‘è‚²å’Œç–¾ç—…ã€‚æœ¬æ–‡ä»‹ç»äº†ä¸€ç§ç³»ç»Ÿï¼Œè¯¥ç³»ç»Ÿå…è®¸äººç±»èƒšèƒå¹²ç»†èƒï¼ˆhESCï¼‰å’Œè¯±å¯¼æ€§å¤šèƒ½å¹²ç»†èƒï¼ˆhiPSCï¼‰åˆ†åŒ–å¹¶å½¢æˆä¸‰ç»´ï¼ˆ3Dï¼‰ç»“æ„ï¼Œä»¥æ¨¡æ‹Ÿè‚ºçš„å‘è‚²ï¼Œç»†èƒç»“æ„å’ŒåŠŸèƒ½ï¼ˆâ€œç±»å™¨å®˜â€ï¼‰åŒ…å«ä¸Šçš®å’Œé—´è´¨ç»†èƒç¾¤ï¼ŒåŒ…æ‹¬è¡¨é¢æ´»æ€§å‰‚çš„äº§ç”Ÿå’Œçº¤æ¯›ç»†èƒçš„å­˜åœ¨ã€‚ç±»å™¨å®˜ä¹Ÿå¯ä»¥ç”¨ä¸­èƒšå±‚è¡ç”Ÿç‰©è¿›è¡ŒæŠ•èµ„ï¼Œè¯¥ä¸­èƒšå±‚è¡ç”Ÿç‰©ä¸ç›¸åŒçš„äººç±»å¤šèƒ½å¹²ç»†èƒï¼ˆå¦‚è‚ºæ³¡å·¨å™¬ç»†èƒå’Œè„‰ç®¡ç³»ç»Ÿï¼‰ä¸åŒã€‚æ­¤ç±»è‚ºç±»å™¨å®˜å¯ç”¨äºç ”ç©¶ç¯å¢ƒä¿®é¥°å‰‚å’Œå¾®æ‰°å‰‚ï¼ˆæ¯’ç´ ï¼Œå¾®ç”Ÿç‰©æˆ–ç—…æ¯’ç—…åŸä½“ï¼Œå¾®ç”Ÿç‰©ç»„æ”¹å˜ï¼‰çš„å½±å“æˆ–è¯ç‰©ï¼Œç”Ÿç‰©åˆ¶å‰‚å’ŒåŸºå› è½¬ç§»çš„åŠŸæ•ˆå’Œå®‰å…¨æ€§ã€‚ Â©2020 Wiley Periodicals LLCã€‚åŸºæœ¬åè®®ï¼šhESC / hiPSCè§£å‰–ï¼Œç¡®å®šçš„å†…èƒšå±‚å½¢æˆå’Œè‚ºç¥–ç»†èƒè¯±å¯¼ã€‚

[1m[33m####################################################################################################[0m

[1m[31mPubmed ID: 32692360[0m

title: Gut Microbiota in T1DM-Onset Pediatric Patients: Machine-Learning Algorithms to Classify Microorganisms as Disease Linked [T1DMå‘ä½œçš„å°å„¿æ‚£è€…è‚ é“èŒç¾¤ï¼šæœºå™¨å­¦ä¹ ç®—æ³•ï¼Œå°†å¾®ç”Ÿç‰©åˆ†ç±»ä¸ºç–¾ç—…ç›¸å…³ç–¾ç—…]

doi: 10.1210/clinem/dgaa407

link_url: https://pubmed.ncbi.nlm.nih.gov/32692360/

journal: J Clin Endocrinol Metab

date: 09/01/2020

enc_abstract: Aims:                    The purpose of this work is to find the gut microbial fingerprinting of pediatric patients with type 1 diabetes.          

cn_abstract: ç›®çš„ï¼šè¿™é¡¹å·¥ä½œçš„ç›®çš„æ˜¯å‘ç°å°å„¿1å‹ç³–å°¿ç—…æ‚£è€…çš„è‚ é“å¾®ç”Ÿç‰©æŒ‡çº¹ã€‚

[1m[33m####################################################################################################[0m

[1m[31mPubmed ID: 32724031[0m

title: Helicobacter pylori and non-alcoholic fatty liver disease [å¹½é—¨èºæ†èŒå’Œéé…’ç²¾æ€§è„‚è‚ªè‚ç–¾ç—…]

doi: 10.23736/S1121-421X.20.02671-9

link_url: https://pubmed.ncbi.nlm.nih.gov/32724031/

journal: Minerva Gastroenterol Dietol

date: 2020 Sep

enc_abstract: Helicobacter pylori is the most prevalent infection worldwide, while non-alcoholic fatty liver disease emerged as the most frequent liver disease. The common occurrence can be either by chance or due to certain pathogenetic factors. Epidemiologic studies revealed that the risk of non-alcoholic liver disease is increased in patients infected with Helicobacter pylori. DNA fragments of Helicobacter pylori were rarely identified in human samples of liver carcinoma and fatty liver. Helicobacter pylori could influence the development of non-alcoholic fatty liver either by hormonal (ghrelin? gastrin? insulin?), or by effect of pro-inflammatory cytokines (interleukin 1 and 8, tumor necrosis factor É‘, interferon É£) and by changes of gut microbiome as well. Probiotic supplementation could improve some clinical parameters of non-alcoholic fatty liver disease and eradication rates of Helicobacter pylori. Regimens used for eradication can be safely administered, although non-alcoholic fatty liver increases the risk of drug-induced liver damage. Controlled studies of the effect of eradication on the development and progression of non-alcoholic fatty liver are warranted.          

cn_abstract: å¹½é—¨èºæ†èŒæ˜¯ä¸–ç•Œä¸Šæœ€æµè¡Œçš„æ„ŸæŸ“ï¼Œè€Œéé…’ç²¾æ€§è„‚è‚ªè‚ç—…åˆ™æ˜¯æœ€å¸¸è§çš„è‚ç—…ã€‚å¸¸è§çš„å‘ç”Ÿå¯èƒ½æ˜¯å¶ç„¶çš„ï¼Œä¹Ÿå¯èƒ½æ˜¯æŸäº›è‡´ç—…å› ç´ å¼•èµ·çš„ã€‚æµè¡Œç—…å­¦ç ”ç©¶è¡¨æ˜ï¼Œæ„ŸæŸ“å¹½é—¨èºæ†èŒçš„æ‚£è€…éé…’ç²¾æ€§è‚ç—…çš„é£é™©å¢åŠ ã€‚åœ¨äººç±»è‚ç™Œå’Œè„‚è‚ªè‚æ ·æœ¬ä¸­å¾ˆå°‘å‘ç°å¹½é—¨èºæ†èŒçš„DNAç‰‡æ®µã€‚å¹½é—¨èºæ†èŒå¯é€šè¿‡æ¿€ç´ ï¼ˆä¿ƒç”Ÿé•¿ç´ é‡Šæ”¾ç´ ï¼Ÿèƒƒæ³Œç´ ï¼Ÿèƒ°å²›ç´ ï¼Ÿï¼‰æˆ–ä¿ƒç‚æ€§ç»†èƒå› å­ï¼ˆç™½ä»‹ç´ 1å’Œ8ï¼Œè‚¿ç˜¤åæ­»å› å­É‘ï¼Œå¹²æ‰°ç´ É£ï¼‰çš„ä½œç”¨æˆ–æ¿€ç´ çš„å˜åŒ–å½±å“éé…’ç²¾æ€§è„‚è‚ªè‚çš„å‘å±•ã€‚è‚ é“å¾®ç”Ÿç‰©ç»„ã€‚è¡¥å……ç›Šç”ŸèŒå¯ä»¥æ”¹å–„ä¸€äº›éé…’ç²¾æ€§è„‚è‚ªè‚çš„ä¸´åºŠå‚æ•°ï¼Œå¹¶èƒ½æ ¹é™¤å¹½é—¨èºæ†èŒã€‚å°½ç®¡éé…’ç²¾æ€§è„‚è‚ªè‚ä¼šå¢åŠ è¯ç‰©å¼•èµ·çš„è‚æŸå®³çš„é£é™©ï¼Œä½†å¯ä»¥å®‰å…¨åœ°ç”¨äºæ ¹é™¤çš„ç–—æ³•ã€‚å¿…é¡»è¿›è¡Œæ ¹é™¤å¯¹éé…’ç²¾æ€§è„‚è‚ªè‚å‘ç”Ÿå’Œå‘å±•çš„å½±å“çš„å¯¹ç…§ç ”ç©¶ã€‚

[1m[33m####################################################################################################[0m

[1m[31mPubmed ID: 32744162[0m

title: The meconium microbiota shares more features with the amniotic fluid microbiota than the maternal fecal and vaginal microbiota [ç¾Šæ°´èŒç¾¤æ¯”äº§å¦‡ç²ªä¾¿å’Œé˜´é“èŒç¾¤å…·æœ‰æ›´å¤šçš„ç¾Šè†œèŒç¾¤ç‰¹å¾ã€‚]

doi: 10.1080/19490976.2020.1794266

link_url: https://pubmed.ncbi.nlm.nih.gov/32744162/

journal: Gut Microbes

date: 11/09/2020

enc_abstract: The early-life gut microbiota is associated with potential development of diseases in adulthood. The sterile womb paradigm has been challenged by recent reports that revealed the presence of the meconium, amniotic fluid, and placenta microbiome. This study aimed to explore the maternal origin of the microbiota of neonate meconium by using the PacBio single-molecule real-time circular consensus sequencing technology. Such technology could produce high fidelity reads of full-length 16S rRNA genes, improving the sensitivity and specificity of taxonomic profiling. It also reduced the risk of false positives. This study analyzed the full-length 16S rRNA-based microbiota of maternal samples (amniotic fluid, feces, vaginal fluid, saliva) and first-pass meconium of 39 maternal-neonate pairs. Alpha- and beta-diversity analyses revealed sample type-specific microbiota features. Most sample types were dominated by sequences representing different genera (Lactobacillus and Curvibacter in the amniotic fluid and vaginal fluid microbiota; Bacillus and Escherichia/Shigella in the meconium microbiota; Bacteroides and Faecalibacterium in the maternal fecal microbiota; Streptococcus and Prevotella in the maternal saliva microbiota). Moreover, specific operational taxonomic units (OTUs) were identified in all sample types. Dyad analysis revealed common OTUs between the meconium microbiota and microbiota of multiple maternal samples. The meconium microbiota shared more features with the amniotic fluid microbiota than the maternal fecal and vaginal microbiota. Our results strongly suggested that the meconium microbiota was seeded from multiple maternal body sites, and the amniotic fluid microbiota contributed most to the seeding of the meconium microbiota among the investigated maternal body sites.          

cn_abstract: æ—©æœŸè‚ é“èŒç¾¤ä¸æˆå¹´æœŸç–¾ç—…çš„æ½œåœ¨å‘å±•æœ‰å…³ã€‚æœ€è¿‘çš„æŠ¥é“æ­ç¤ºäº†èƒç²ªï¼Œç¾Šæ°´å’Œèƒç›˜å¾®ç”Ÿç‰©ç»„çš„å­˜åœ¨ï¼Œå¯¹æ— èŒå­å®«èŒƒä¾‹æå‡ºäº†æŒ‘æˆ˜ã€‚æœ¬ç ”ç©¶æ—¨åœ¨é€šè¿‡ä½¿ç”¨PacBioå•åˆ†å­å®æ—¶å¾ªç¯å…±æœ‰åºåˆ—æµ‹åºæŠ€æœ¯æ¢ç´¢æ–°ç”Ÿå„¿èƒç²ªå¾®ç”Ÿç‰©ç¾¤çš„æ¯æºã€‚æ­¤ç±»æŠ€æœ¯å¯ä»¥äº§ç”Ÿå…¨é•¿16S rRNAåŸºå› çš„é«˜ä¿çœŸè¯»æ•°ï¼Œä»è€Œæé«˜åˆ†ç±»å­¦åˆ†æçš„æ•æ„Ÿæ€§å’Œç‰¹å¼‚æ€§ã€‚è¿™ä¹Ÿå‡å°‘äº†è¯¯æŠ¥çš„é£é™©ã€‚è¿™é¡¹ç ”ç©¶åˆ†æäº†å­•å¦‡æ ·å“ï¼ˆç¾Šæ°´ï¼Œç²ªä¾¿ï¼Œé˜´é“æ¶²ï¼Œå”¾æ¶²ï¼‰å’Œ39å¯¹å­•å¦‡-æ–°ç”Ÿå„¿çš„é¦–è¿‡èƒç²ªçš„å…¨é•¿åŸºäº16S rRNAçš„å¾®ç”Ÿç‰©ç¾¤ã€‚ Î±å’ŒÎ²å¤šæ ·æ€§åˆ†ææ­ç¤ºäº†æ ·å“ç±»å‹ç‰¹å¼‚æ€§çš„å¾®ç”Ÿç‰©ç¾¤ç‰¹å¾ã€‚å¤§å¤šæ•°æ ·å“ç±»å‹ç”±ä»£è¡¨ä¸åŒå±çš„åºåˆ—å†³å®šï¼ˆç¾Šæ°´å’Œé˜´é“èŒç¾¤ä¸­çš„ä¹³é…¸æ†èŒå’Œå¼¯æ›²æ†èŒï¼›èƒç²ªèŒç¾¤ä¸­çš„æ†èŒå’Œå¤§è‚ åŸƒå¸Œæ°èŒï¼›å¿—è´ºæ°èŒåœ¨äº§å¦‡ç²ªä¾¿èŒç¾¤ä¸­ï¼›æ‹Ÿæ†èŒå’Œè´¹æ°æ†èŒï¼›å­•å¦‡å”¾æ¶²èŒç¾¤ä¸­çš„é“¾çƒèŒå’Œæ™®åˆ—ç‰¹æ†èŒã€‚ ï¼‰ã€‚æ­¤å¤–ï¼Œåœ¨æ‰€æœ‰æ ·æœ¬ç±»å‹ä¸­éƒ½ç¡®å®šäº†ç‰¹å®šçš„æ“ä½œåˆ†ç±»å•ä½ï¼ˆOTUï¼‰ã€‚ Dyadåˆ†ææ­ç¤ºäº†èƒç²ªå¾®ç”Ÿç‰©ç¾¤å’Œå¤šä¸ªæ¯ä½“æ ·å“çš„å¾®ç”Ÿç‰©ç¾¤ä¹‹é—´å¸¸è§çš„OTUã€‚ç¾Šæ°´èŒç¾¤æ¯”äº§å¦‡ç²ªä¾¿å’Œé˜´é“èŒç¾¤å…·æœ‰æ›´å¤šçš„ç¾Šè†œèŒç¾¤ç‰¹å¾ã€‚æˆ‘ä»¬çš„ç»“æœæœ‰åŠ›åœ°è¡¨æ˜ï¼Œèƒç²ªå¾®ç”Ÿç‰©ç¾¤æ˜¯ä»å¤šä¸ªå­•äº§å¦‡èº«ä½“éƒ¨ä½æ’­ç§çš„ï¼Œè€Œç¾Šæ°´å¾®ç”Ÿç‰©ç¾¤å¯¹èƒç²ªå¾®ç”Ÿç‰©èŒç¾¤çš„æ’­ç§è´¡çŒ®æœ€å¤§ã€‚

[1m[33m####################################################################################################[0m

[1m[31mPubmed ID: 32744583[0m

title: Are nutrition and physical activity associated with gut microbiota? A pilot study on a sample of healthy young adults [è¥å…»å’Œèº«ä½“æ´»åŠ¨ä¸è‚ é“èŒç¾¤æœ‰å…³å—ï¼Ÿå¯¹å¥åº·çš„å¹´è½»äººæ ·æœ¬è¿›è¡Œçš„åˆæ­¥ç ”ç©¶]

doi: 10.7416/ai.2020.2372

link_url: https://pubmed.ncbi.nlm.nih.gov/32744583/

journal: Ann Ig

date: Sep-Oct 2020

enc_abstract: Background:                    The literature shows that gut microbiota composition is related with health, and a lot of individual and outer factors may determine its variability. In particular, nutrition and exercise seem to influence the presence in the gut of the two major bacterial phyla of Firmicutes and Bacteroidetes.          

cn_abstract: èƒŒæ™¯ï¼šæ–‡çŒ®è¡¨æ˜è‚ é“èŒç¾¤çš„ç»„æˆä¸å¥åº·æœ‰å…³ï¼Œè®¸å¤šä¸ªä½“å’Œå¤–éƒ¨å› ç´ å¯èƒ½å†³å®šå…¶å˜å¼‚æ€§ã€‚ç‰¹åˆ«æ˜¯ï¼Œè¥å…»å’Œè¿åŠ¨ä¼¼ä¹ä¼šå½±å“åˆ°è‚ èƒƒèŒå’Œæ‹Ÿæ†èŒçš„ä¸¤ä¸ªä¸»è¦ç»†èŒèŒç¾¤åœ¨è‚ é“ä¸­çš„å­˜åœ¨ã€‚

[1m[33m####################################################################################################[0m

[1m[31mPubmed ID: 32752913[0m

title: Alternations of gut microbiota composition in neonates conceived by assisted reproductive technology and its relation to infant growth [è¾…åŠ©ç”Ÿæ®–æŠ€æœ¯å¯¹æ–°ç”Ÿå„¿è‚ é“èŒç¾¤ç»„æˆçš„æ”¹å˜åŠå…¶ä¸å©´å„¿ç”Ÿé•¿çš„å…³ç³»]

doi: 10.1080/19490976.2020.1794466

link_url: https://pubmed.ncbi.nlm.nih.gov/32752913/

journal: Gut Microbes

date: 11/09/2020

enc_abstract: The gut microbiome in newborns may be strongly influenced by their intrinsic host microenvironmental factors (e.g., the gestational age) and has been linked to their short-term growth and potentially future health. It is yet unclear whether early microbiota composition is significantly different in newborns conceived by assisted reproductive technology (ART) when compared with those who were conceived spontaneously. Additionally, little is known about the effect of gut microbiota composition on weight gain in early infancy. We aimed to characterize the features and the determinants of the gut microbiome in ART newborns and to assess the impact of early microbiota composition on their weight gain in early infancy in mother-infant dyads enrolled in the China National Birth Cohort (CNBC). Among 118 neonates born by ART and 91 neonates born following spontaneous conception, we observed significantly reduced gut microbiota Î±-diversity and declined Bacteroidetes relative abundance in ART neonates. The microbiota composition of ART neonates was largely driven by specific ART treatments, hinting the importance of fetus intrinsic host microenvironment on the early microbial colonization. Following up these neonates for six months after their births, we observed the effects of gut microbiome composition on infant rapid weight gaining. Collectively, we identified features and determinants of the gut microbiota composition in ART neonates, and provided evidence for the importance of microbiota composition in neonatal growth.          

cn_abstract: æ–°ç”Ÿå„¿çš„è‚ é“å¾®ç”Ÿç‰©ç»„å¯èƒ½ä¼šå—åˆ°å…¶å†…åœ¨çš„å®¿ä¸»å¾®ç¯å¢ƒå› ç´ ï¼ˆä¾‹å¦‚èƒé¾„ï¼‰çš„å¼ºçƒˆå½±å“ï¼Œå¹¶ä¸”ä¸ä»–ä»¬çš„çŸ­æœŸç”Ÿé•¿å’Œæœªæ¥çš„å¥åº·çŠ¶å†µæœ‰å…³ã€‚å°šä¸æ¸…æ¥šï¼Œä¸è‡ªç„¶æ€€å­•çš„å©´å„¿ç›¸æ¯”ï¼Œè¾…åŠ©ç”Ÿæ®–æŠ€æœ¯ï¼ˆARTï¼‰æ€€å­•çš„å©´å„¿çš„æ—©æœŸèŒç¾¤ç»„æˆæ˜¯å¦æ˜¾ç€ä¸åŒã€‚å¦å¤–ï¼Œå…³äºå©´å„¿æ—©æœŸè‚ é“èŒç¾¤ç»„æˆå¯¹ä½“é‡å¢åŠ çš„å½±å“çŸ¥ä¹‹ç”šå°‘ã€‚æˆ‘ä»¬æ—¨åœ¨è¡¨å¾ARTæ–°ç”Ÿå„¿ä¸­è‚ é“å¾®ç”Ÿç‰©ç»„çš„ç‰¹å¾å’Œå†³å®šå› ç´ ï¼Œå¹¶è¯„ä¼°åœ¨ä¸­å›½å‡ºç”Ÿé˜Ÿåˆ—ï¼ˆCNBCï¼‰ä¸­ç™»è®°çš„æ¯äºŒå€ä½“ä¸­æ—©æœŸèŒç¾¤ç»„æˆå¯¹å…¶æ—©æœŸä½“é‡å¢åŠ çš„å½±å“ã€‚åœ¨ARTå‡ºç”Ÿçš„118ä¾‹æ–°ç”Ÿå„¿å’Œè‡ªç„¶å—å­•åçš„91ä¾‹æ–°ç”Ÿå„¿ä¸­ï¼Œæˆ‘ä»¬è§‚å¯Ÿåˆ°ARTæ–°ç”Ÿå„¿çš„è‚ é“èŒç¾¤Î±å¤šæ ·æ€§æ˜¾ç€é™ä½ï¼Œæ‹Ÿæ†èŒçš„ç›¸å¯¹ä¸°åº¦ä¸‹é™ã€‚ ARTæ–°ç”Ÿå„¿çš„å¾®ç”Ÿç‰©ç¾¤ç»„æˆå¾ˆå¤§ç¨‹åº¦ä¸Šå—ç‰¹å®šçš„ARTæ²»ç–—é©±åŠ¨ï¼Œè¿™æš—ç¤ºäº†èƒå„¿å›ºæœ‰å®¿ä¸»å¾®ç¯å¢ƒå¯¹æ—©æœŸå¾®ç”Ÿç‰©å®šæ®–çš„é‡è¦æ€§ã€‚åœ¨è¿™äº›æ–°ç”Ÿå„¿å‡ºç”Ÿåå…­ä¸ªæœˆè¿›è¡Œéšè®¿ï¼Œæˆ‘ä»¬è§‚å¯Ÿåˆ°è‚ é“å¾®ç”Ÿç‰©ç»„ç»„æˆå¯¹å©´å„¿å¿«é€Ÿå¢é‡çš„å½±å“ã€‚æˆ‘ä»¬å…±åŒç¡®å®šäº†ARTæ–°ç”Ÿå„¿è‚ é“èŒç¾¤ç»„æˆçš„ç‰¹å¾å’Œå†³å®šå› ç´ ï¼Œå¹¶ä¸ºå¾®ç”Ÿç‰©èŒç¾¤ç»„æˆåœ¨æ–°ç”Ÿå„¿ç”Ÿé•¿ä¸­çš„é‡è¦æ€§æä¾›äº†è¯æ®ã€‚

[1m[33m####################################################################################################[0m

